
| Product Name | CAS | MF | MW | Synonyms |
|---|---|---|---|---|
| (±)15-HEPE | 88852-33-9 | C20H30O3 | 318.45 | (+/-)15-HEPE; (+/-)-15-HYDROXY-5Z,8Z,11Z,13E,17Z-EICOSAPENTAENOIC ACID; (+/-)-15-Hydroxy-5Z,8Z,11Z,13E,17Z-eicosadienoic acid |
| (±)13-HDoHE | 90780-53-3 | C22H32O3 | 344.48768 | (+/-)13-HDOHE; 13-HYDROXY DOCOSAHEXAENOIC ACID; (+/-)13-HYDROXY-4Z,7Z,10Z,14E,16Z,19Z-DOCOSAHEXAENOIC ACID |
| (±)12-HpETE | 71030-35-8 | C20H32O4 | 336.47 | 12-HYDROPEROXY-5Z,8Z,10E,14Z-EICOSATETRAENOIC ACID; (+/-)12-HPETE; 12-Hydroperoxy-5,8,10,14-icosatetraenoic acid |
| (±)12-HEPE | 81187-21-5 | C20H30O3 | 318.45 | (+/-)12-HEPE; (+/-)-12-HYDROXY-5Z,8Z,10E,14Z,17Z-EICOSAPENTAENOIC ACID; (5Z,8Z,10E,12S,14Z,17Z)-12-Hydroxy-5,8,10,14,17-icosapentaenoic acid |
| (±)12,13-DiHOME | 263399-35-5 | C18H34O4 | 314.5 | |
| (±)11-HEPE | 99217-78-4 | C20H30O3 | 318.45 | (+/-)11-HEPE; (+/-)-11-HYDROXY-5Z,8Z,12E,14Z,17Z-EICOSAPENTAENOIC ACID; (+/-)-11-Hydroxy-5Z,8Z,12E,14Z,17Z-eicosatetraenoic acid |
| (±)11-HDoHE | 87018-59-5 | C22H32O3 | 344.48768 | (+/-)11-HYDROXY-4Z,7Z,9E,13Z,16Z,19Z-DOCOSAHEXAENOIC ACID; 11-HYDROXY DOCOSAHEXAENOIC ACID; (+/-)11-HDOHE |
| (±)-1-(p-Hydroxyphenoxy)-3-[2-(morpholinocarbonamido)ethylamino]-2-propanol hemifumarate | 90730-93-1 | C20H29N3O9 | 455.46883 | |
| (±)-(R*,S*)-4-[3-(4-Fluorophenyl)-2-hydroxy-1-(1,2,4-triazol-1-yl)propyl]benzonitrile | 160146-17-8 | C18H15FN4O | 322.34485 | AC1OCF8H; MPV-2213ad; SCHEMBL2138489; ZINC6079; UNII-40028KHQ6BcomponentSLJZVZKQYSKYNV-ZWKOTPCHSA-N; 4-[(1R,2S)-1-(1H-1,2,4-Triazole-1-yl)-2-hydroxy-3-(4-fluorophenyl)propyl]benzonitrile |
| (±)-(3RS,3'RS)-3,3'-[(2,2-dimethyltrimethylene)-diimino]di-2-butanone | 10613-48-7 | C13H28N4O2 | 272.39 | |
| (+/-)-TROPANYL 2-(4-CHLOROPHENOXY)BUTANOATE MALEATE | 155058-71-2 | C22H28ClNO7 | 453.91 | SM-21 MALEATE; SM21; (+/-)-TROPANYL 2-(4-CHLOROPHENOXY)BUTANOATE MALEATE; TROPANYL 2-(4-CHLOROPHENOXY)BUTANOATE MALEATE; TROPINE 2-(4-CHLOROPHENOXY)BUTANOATE MALEATE SALT |
| (+/-)-trans-U-50488 methanesulfonate salt | 83913-05-7 | C19H26Cl2N2O . CH4O3S | 465.43 | TRANS-(+/-)-3,4-DICHLORO-N-METHYL-N-(2-[1-PYRROLIDINYL]CYCLOHEXYL) BENZENEACETAMIDE METHANESULFONATE; TRANS-(+/-)-3,4-DICHLORO-N-METHYL-N-(2-[1-PYRROLIDINYL]CYCLOHEXYL)-BENZENEACETAMIDE METHANESULFONATE SALT; U-50488H; trans-(+-)-3,4-dichloro-N-methyl-N-( |
| (+/-)-TRANS-N-BOC-4-METHYL-PIPECOLINIC ACID | 123811-83-6 | C12H21NO4 | 243.3 | (+/-)-CIS-N-BOC-4-METHYL-PIPECOLINIC ACID; (+/-)-TRANS-N-BOC-4-METHYL-PIPECOLINIC ACID |
| (+/-)-TRANS-4-(FLUOROPHENYL)-3-HYDROXYMETHYL-1-METHYLPIPERIDINE | 318279-38-8 | C13H18FNO | 223.29 | (+/-)-TRANS-4-(4-FLUOROPHENYL)-3-HYDROXYMETHYL-1-METHYLPIPERIDINE; TRANS(+/-)-4-(4-FLUOROPHENYL)-3-HYDROXYMETHYL-1-METHYLPIPERIDINE; TRANS-4-(4-FLUOROPHENYL)-3-HYDROXYMETHYL-1-METHYLPIPERIDINE; (+/-)-TRANS-4-(FLUOROPHENYL)-3-HYDROXYMETHYL-1-METHYLPIPERIDI |
| (+/-)-TRANS-1,2-CYCLOPENTANEDIOL | 86703-52-8 | C5H10O2 | 102.13 | (+/-)-TRANS-1,2-CYCLOPENTANEDIOL; TRANS-1,2-CYCLOPENTANEDIOL |
| (+/-)-TRANS-1,2-CYCLOHEXANEDICARBOXYLIC ANHYDRIDE | 14166-21-3 | C8H10O3 | 154.16 | (+/-)-TRANS-1,2-CYCLOHEXANEDICARBOXYLIC ANHYDRIDE; TRANS-1,2-CYCLOHEXANEDICARBOXYLIC ANHYDRIDE; TRANS-HEXAHYDROPHTHALIC ANHYDRIDE; 1,3-Isobenzofurandione, hexahydro-, trans-; trans-cyclohexane-1,2-dicarboxylic anhydride; Einecs 238-009-9 |
| (+/-)-TRANS-1,2-BIS(CHLOROACETAMIDO)CYCLOHEXANE | 150576-46-8 | C10H16Cl2N2O2 | 267.15 | (+/-)-TRANS-1,2-BIS(CHLOROACETAMIDO)CYCLOHEXANE |
| (+/-)-TRANS-1,2-BIS(2-MERCAPTOACETAMIDO)CYCLOHEXANE | 257641-01-3 | C10H18N2O2S2 | 262.396 | rel-N,N'-(1R,2R)-1,2-Cyclohexanediylbis[2-mercapto-acetamide; Vectrase P; BMC |
| (+/-)-THREO-9,10-DIHYDROXY-12(Z)-OCTADECENOIC ACID | 263399-34-4 | C18H34O4 | 314.46 | (+/-)-THREO-9,10-DIHYDROXY-12(Z)-OCTADECENOIC ACID; LEUKOTOXIN DIOL; (+/-)9,10-DIHOME; (+/-)9(10)-DIHYDROXY-12Z-OCTADECENOIC ACID |
| (+/-)-SALSOLINOL HYDROCHLORIDE | 70681-20-8 | C10H14ClNO2 | 215.68 | (+/-)-SALSOLINOL HYDROCHLORIDE; 1-METHYL-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE; 1-METHYL-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROCHLORIDE; (+/-)-SalsolinolHCl; DL-1-METHYL-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE HCL |
| (+/-)-Rac-2-(2-chlorophenyl)-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetonitrile | 444728-11-4 | C15H13ClN2S | 288.8 | (+/-)-RAC-2-(2-CHLOROPHENYL)-(6,7-DIHYDRO-4H-THIENO[3,2-C]PYRIDIN-5-YL)ACETONITRILE |
| (+/-)-o-Cotinine | 147732-31-8 | C10H12N2O | 176.22 | 1-Methyl-5-(2-pyridyl)-2-pyrrolidinone; (R,S)-ortho-Cotinine |
| (+/-)-Naringenin | 93602-28-9 | C15H12O5 | 272.30 | TIMTEC-BB SBB006461; 5,7,4'-TRIHYDROXYFLAVANONE; 5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)CHROMAN-4-ONE; (+/-)-2,3-DIHYDRO-5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; (+/-)-4',5,7-Trihydroxyflavanone; (+/-)-Naringenin |
| (+/-)-N,N-Dimethyl-1-(2-diphenylphosphino)ferrocenylethylamine 1-hydrate | 60816-98-0 | C26H28FeNP.H2O | 459.34 | (+/-)-N,N-DIMETHYL-1-(2-DIPHENYLPHOSPHINO)FERROCENYLETHYLAMINE MONOHYDRATE; (+/-)-N,N-Dimethyl-1-(2-diphenylphosphino)ferrocenylethylamine; (n)-n,n-dimethyl-1-(2-diphenylphosphino)ferrocenylethylamine monohydrate |
| (+/-)-MUSCARINE CHLORIDE | 2936-25-6 | C9H20ClNO2 | 209.71 | (+)-MUSCARINE; (+/-)-MUSCARINE CHLORIDE; TETRAHYDRO-4-HYDROXY-N,N,N,5-TETRAMETHYL-2-FURANMETHANAMMONIUM CHLORIDE; (+/-)-muscarine chloride approx. 95%; (+/-)-MUSCARINE CHLORIDE SYNTHETIC >99%; DL-MUSCARINECHLORIDE |
| (+/-)-MEPHENYTOIN | 74007-05-9 | C12H14N2O2 | 218.25200 | |
| (+/-)-Lavandulol | 1845-51-8 | C10H18O | 154.25 | (+/-)-LAVANDULOL; (+/-)-2-ISOPROPENYL-5-METHYL-4-HEXEN-1-OL; (+-)-LAVANDULOL TECHN. 90+%; 5-methyl-2-prop-1-en-2-yl-hex-4-en-1-ol; 5-methyl-2-prop-1-en-2-ylhex-4-en-1-ol |
| (+/-)-Hydrobenzoin | 655-48-1 | C14H14O2 | 214.26 | (+/-)-1,2-DIPHENYL-1,2-ETHANEDIOL; 1,2-DIPHENYL-1,2-ETHANEDIOL; (+/-)-HYDROBENZOIN; HYDROBENZOIN; D,L-1,2-DIPHENYL-1,2-ETHANEDIOL RACEMATE; RAC HYDROBENZOIN; Hydrobenzoin (racemic); (n)-1,2-diphenyl-1,2-ethanediol |
| (+/-)-Homohistidine | 5817-77-6 | C7H11N3O2 | 169.18 | (+/-)-HOMOHISTIDINE |
| (+/-)-E-10-HYDROXYLATED-NORTRIPTYLINE METABOLITE MALEATE SALT | 37439-89-7 | C23H25NO5 | 395.45 | (+/-)-E-3-(10-HYDROXY-10,11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTEN-5-YLIDENE)-N-METHYL-1-PROPANAMINE MALEATE; (+/-)-E-10-HYDROXYLATED-NORTRIPTYLINE METABOLITE MALEATE SALT; E-10-HYDROXYNORTRIPTYLINE MALEATE SALT; NORTRYPTYLINE METABOLITE (+-)-E-10-HYDRO XY-LA |
| (+/-)-DIHYDROJASMONIC ACID | 76968-33-7 | C12H20O3 | 212.29 | (+/-)-DIHYDROJASMONIC ACID; 2-AMYL-3-(CARBOXYMETHYL)CYCLOPENTANONE; 2-AMYL-3-OXOCYCLOPENTANEACETIC ACID; 3-OXO-2-PENTYLCYCLOPENTANEACETIC ACID; 3-(CARBOXYMETHYL)-2-PENTYLCYCLOPENTANONE |
| (+/-)-Cryptostyline | 22324-83-0 | C21H27NO5 | 373.44 | 6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinoline; 22324-83-0; CRYPTOSTYLINEIII; AC1MDDGA; (+/-)-Cryptostyline; Ambcb5224665 |
| (+/-)-CIS-EPOXYTRICARBALLYLIC ACID POTASSIUM SALT | 85431-33-0 | C6H5KO7 | 228.2 | |
| (+/-)-CIS-3-METHYL-2-PIPERIDINECARBOXYLIC ACID | 123719-65-3 | C7H13NO2 | 143.18 | (+/-)-CIS-3-METHYL-2-PIPERIDINECARBOXYLIC ACID; 2-Piperidinecarboxylicacid,3-methyl-,cis-(9CI) |
| (+/-)Cis-2,5-bis(3,4,5-trimethoxyphenyl)-1,3-dioxolane | 116673-47-3 | C21H26O8 | 406.43 | (+/-) CIS-2,5-BIS(3,4,5-TRIMETHOXYPHENYL)-1,3-DIOXOLANE |
| (+/-)-Chelidonine | 20267-87-2 | C19H17N3O3 | 371.38 | (+/-)-Chelidonine; Chelidonine 1-hydrate |
| (+/-)-7-HYDROXY-2-DIPROPYLAMINOTETRALIN HYDROBROMIDE | 159795-63-8 | C16H26BrNO | 328.29 | 7-HYDROXY-DPAT HBR; 7-HYDROXY-DPAT HYDROBROMIDE; 7-OH-DPAT HBR; (+/-)-7-OH-DPAT HYDROBROMIDE; [+/-]-7-OH-DPAT HYDROBROMIDE; (+/-)-7-HYDROXY-2-DIPROPYLAMINOTETRALIN HYDROBROMIDE; (+/-)-7-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN HYDROBROMIDE; (+/-)-7-HYDROXY-2- |
| (+/-)5-HETRE | 88053-46-7 | C20H34O3 | 322.48 | (+/-)5-HETRE; (+/-)5-HYDROXYEICOSA-6E,8Z,11Z-TRIENOIC ACID |
| (+/-)5-HETE METHYL ESTER | 73279-38-6 | C21H34O3 | 334.49 | (+/-)5-HYDROXY-6E,8Z,11Z,14Z-EICOSATETRAENOIC ACID, METHYL ESTER; (+/-)5-HETE METHYL ESTER; (+/-)-5-HYDROXY-(6E,8Z,11Z,14Z)-*EICOSAT ETRAENOIC A |
| (+/-)5-HEPE | 112572-25-5 | C20H30O3 | 318.45 | (+/-)5-HEPE; (+/-)5-HYDROXYEICOSA-6E,8Z,11Z,14Z,17Z-PENTAENOIC ACID; (+/-)-5-HYDROXY-6E,8Z,11Z,14Z,17Z-EICOSAPENTAENOIC ACID; (+-)-5-hydroxy-(6E,8Z,11Z,14Z,17Z)-*eicosapentaen; (+-)-5-HYDROXY-(6E,8Z,11Z,14Z,17Z)-*EICO SAPENTAENOI |
| (+/-)5(6)-EPOXY-8Z,11Z,14Z,17Z-EICOSATETRAENOIC ACID, METHYL ESTER | 127716-49-8 | C21H32O3 | 332.48 | (+/-)5(6)-EPOXY-8Z,11Z,14Z,17Z-EICOSATETRAENOIC ACID, METHYL ESTER; 5,6-EPOXY EICOSATETRAENOIC ACID METHYL ESTER; 5(6)-EPETE METHYL ESTER |
| (+/-)5(6)-EET methyl ester | 122799-12-6 | C21H34O3 | 334.49 | (+/-)5(6)-EPETRE METHYL ESTER; (+/-)5(6)-EPOXY-8Z,11Z,14Z-EICOSATRIENOIC ACID, METHYL ESTER; (+/-)-5,6-EPOXYEICOSA-8Z,11Z,14Z-TRIENOIC ACID METHYL ESTER; (+/-)5,6-EET METHYL ESTER; 5,6-EET METHYL ESTER; 5(6)-EPETRE |
| (+/-)4-Hydroxynon-2-enal | 128946-65-6 | C9H16O2 | 156.2 | (E)-4-HYDROXYNONENAL, >85% |
| (+/-)-3-HYDROXY-2-(2-PENTENYL)CYCLOPENTANEACETIC ACID | 131488-83-0 | C12H20O3 | 212.29 | (+/-)-3-HYDROXY-2-(2-PENTENYL)CYCLOPENTANEACETIC ACID; (+/-)-CUCURBIC ACID; (+/-)-CUCURBIC ACID, (5MG/ML IN ACETONITRILE) |
| (+/-)-3-AMINO-1-HYDROXY-2-PYRROLIDONE | 70996-07-5 | C4H8N2O2 | 116.12 | (+/-)-HA-966; (+/-)-3-AMINO-1-HYDROXY-2-PYRROLIDONE; (3R)-1-Hydroxy-3-amino-2-pyrrolidone; (3R)-1-Hydroxy-3-aminopyrrolidine-2-one; [3R,(+)]-3-Amino-1-hydroxypyrrolidin-2-one |
| (+/-)-3,7-DimethyloCt-6-en-1-ol | 26489-01-0 | C10H20O | 156.27 | RHODINOL; 7-dimethyl-(+/-)-6-octen-1-o; FEMA 2309; FEMA 2307; CITRONELLOL, DL-B-; CITRONELLOL AJ |
| (+/-)-2-Methylnicotine | 64114-31-4 | C11H16N2 | 176.26 | 3-Methyl-2-(1-methyl-2-pyrrolidinyl)pyridine |
| (+/-)2-Mercapto-2-methylpentan-1-ol | 258823-39-1 | C6H14OS | 134.24 | (+/-)2-MERCAPTO-2-METHYLPENTAN-1-OL; 2-MERCAPTO-2-METHYL-1-PENTANOL |
| (+/-)-2-HYDROXYUNDECANOIC ACID | 19790-86-4 | C11H22O3 | 202.29 | (+/-)-2-HYDROXYUNDECANOIC ACID |
| (+/-)-2-HYDROXYNONANOIC ACID | 70215-04-2 | C9H18O3 | 174.24 | ALPHA-HYDROXY NONANOIC ACID; (+/-)-2-HYDROXYNONANOIC ACID; (+/-)-2-Hydroxyninanoic acid |
| (+/-)-2-Hydroxy-3-buten-1-yl tosylate | 138332-13-5 | C11H14O4S | 242.29146 | (+/-)-2-Hydroxy-3-buten-1-yl tosylate |
| (+/-)-2-ENDO-AMINO-3-EXO-ISOPROPYLBICYCLO[2.2.1]HEPTANE HYDROCHLORIDE | 175521-95-6 | C10H20ClN | 189.73 | AGN 192403 HYDROCHLORIDE; (+/-)-2-ENDO-AMINO-3-EXO-ISOPROPYLBICYCLO[2.2.1]HEPTANE HYDROCHLORIDE; AGN 192403; Bicyclo[2.2.1]heptan-2-amine, 3-(1-methylethyl)-, (1R,2R,3R,4S)-rel- (9CI); AGN192403HCl; (2-endo, 3-exo)-3-(Methylethyl)-bicyclo[2.2.1]heptan-2- |
| (+/-)-2-CHLOROBUTANE-D9 | 175540-77-9 | 0 | ||
| (+/-)-2-Bromopentane | 130321-66-3 | CxHyBr | 151.0474 | 2-bromopentane; 2-BROMOPENTANE; 107-81-3; 2-Pentylbromide; Pentane,2-bromo-; (+/-)-2-Bromopentane |
| (+/-)-2-AMINO-7-PHOSPHONOHEPTANOIC | 85797-13-3 | C7H16NO5P | 0 | (+/-)-2-AMINO-7-PHOSPHONOHEPTANOIC; 2-amino-7-phosphono-heptanoicaci; Brn 3544152; Heptanoic acid, 2-amino-7-phosphono- |
| (+/-)-2-AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE HYDROBROMIDE | 73304-33-3 | C10H14BrNO2 | 260.13 | DOPAMINE AGONIST, HYDROBROMIDE; (+/-)-2-AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE HBR; 2-AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE, HBR; (+/-)-2-AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE HYDROBROMIDE; 6,7-ADTN HBR; 6,7-ADTN HYDROBR |
| (+/-)-2-Acetylaminobutanoic acid | 114285-09-5 | C6H11NO3 | 145.157 | (±)-2-Acetylaminobutanoic Acid; 3-(Acetylamino)-3-carboxypropy; (3-(Acetylamino)-3-carboxypropyl) |
| (+/-)-1-Phenylethanol | 13323-81-4 | C8H10O | 122.16 | (+/-)-1-Phenylethanol; 1-Phenylethanol; DL-1-Phenylethyl alcohol |
| (+/-)-1-Oleoyl-2-acetylglycerol | 92282-11-6 | C23H42O5 | 398.58 | OAG; 18:1-2:0 DG; 1-OLEOYL-2-ACETOYL-SN-GLYCEROL; (+/-)-1-OLEOYL-2-ACETYLGLYCEROL; 1-oleoyl-2-acetyl-rac-glycerol*(C18:1,(cis)-9/C2:; 1-OLEOYL-2-ACETYL-RAC-GLYCEROL (C18:1,(CIS)-9/C2:0); 2-acetyl-1-oleoyl-rac-glycerol; 1-Oleoyl-2-acetyl-rac-glycerol |
| (+/-)-1-Methyl-4-(1-methylvinyl)cyclohexene | 7705-14-8 | C10H16 | 136.23 | (+/-)-1-Methyl-4-(1-methylvinyl)cyclohexene; Terpineolene |
| (+/-)-1-AMINOCYCLOPENTANE-CIS-1,2-DICARBOXYLIC ACID | 39026-64-7 | C7H11NO4 | 173.17 | CIS-1,2-ACPD; (+/-)-1-AMINOCYCLOPENTANE-CIS-1,2-DICARBOXYLIC ACID; 1-AMINOCYCLOPENTANE-CIS-1,2-DICARBOXYLIC ACID; (+/-)-1-aminocyclopentane-trans-1,3-*dicarboxylic |
| (+/-)-15-HYDROXY-11Z,13E-EICOSADIENOIC ACID | 77159-57-0 | C20H36O3 | 324.5 | (+/-)15-HEDE; (+/-)-15-HYDROXY-11Z,13E-EICOSADIENOIC ACID |
| (+/-)15-HETE | 73836-87-0 | C20H32O3 | 320.47 | (+/-)15-HETE; (+/-)15-HYDROXY-5Z,8Z,11Z,13E-EICOSATETRAENOIC ACID; (5Z,8Z,11Z,14Z)-15-Hydroxy-5,8,11,14-icosatetraenoic acid |
| (+/-)14(15)-EPOXY-5Z,8Z,11Z,17Z-EICOSATETRAENOIC ACID | 131339-24-7 | C20H32O3 | 320.47 | 14,15-EPOXY EICOSATETRAENOIC ACID; (+/-)14(15)-EPOXY-5Z,8Z,11Z,17Z-EICOSATETRAENOIC ACID; 14(15)-EPETE |
| (+/-)14(15)-EPETRE METHYL ESTER | 73804-67-8 | C21H34O3 | 334.49 | 14,15-EET METHYL ESTER; (+/-)14(15)-EPOXY-5Z,8Z,11Z-EICOSATRIENOIC ACID, METHYL ESTER; (+/-)14(15)-EPETRE METHYL ESTER |
| (+/-)-11-HYDROXY-12E,14Z-EICOSADIENOIC ACID | 5598-37-8 | C20H36O3 | 324.5 | (+/-)11-HEDE; (+/-)-11-HYDROXY-12E,14Z-EICOSADIENOIC ACID |
| (+/-)11-HETE | 73804-65-6 | C20H32O3 | 320.47 | (+/-)11-HETE; (+/-)11-HYDROXY-5Z,8Z,12E,14Z-EICOSATETRAENOIC ACID |
| (+/-)-1,2-Didecanoylglycerol | 82950-64-9 | C23H44O5 | 400.59 | DIDECANOIN; DICAPRIN; 10:0 DG; 1,2-DICAPRIN; 1,2-DICAPRYL-SN-GLYCEROL; (+/-)-1,2-DIDECANOYLGLYCEROL; 1,2-DIDECANOYL-RAC-GLYCEROL; 1,2-didecanoyl-rac-glycerol (C10:0) |
| (+/-)-1,1'-Binaphthyl-2,2'-diyl hydrogen phosphate | 50574-52-2 | C20H13O8P2 | 443.26000 | |
| (+/-)-1,1'-bi-2-Naphthol dimethyl ether | 75685-01-7 | C22H18O2 | 314.38 | (R)-(+)-1,1'-BI-2-NAPHTHOL DIMETHYL ETHER; (R)-(+)-2,2'-DIMETHOXY-1,1'-BINAPHTHYL; (R)-2,2'-DIMETHOXY-1,1'-BINAPHTHYL; (R)-(+)-2,2'-DIMETHOXY-1,1'-BI-NAPHTHOL; (S)-(-)-2,2'-DIMETHOXY-1,1'-BINAPHTHYL; (S)-(+)-2,2'-DIMETHOXY-1,1'-BINAPHTHYL; (S)-2,2'-DIMETH |
| (+/-)-1-(4-BROMOPHENYL)ETHYL ISOCYANATE | 207974-15-0 | C9H8BrNO | 226.07 | (+/-)-1-(4-BROMOPHENYL)ETHYL ISOCYANATE; 1-(4-BROMOPHENYL)ETHYL ISOCYANATE; 4-Bromo-alpha-methylbenzyl isocyanate; (n)-1-(4-bromophenyl)ethyl isocyanate; 4-bromo-à-methylbenzyl isocyanate |
| (+/-)-1-(1-Naphthyl)ethanol | 57605-95-5 | C12H12O | 172.22 | ALPHA-METHYL-1-NAPHTHALENEMETHANOL; ALPHA-NAPHTHYL METHYL CARBINOL; A-NAPHTHYLMETHYLCARBINOL; 1-(1-HYDROXYETHYL)NAPHTHALENE; (+/-)-1-(1-NAPHTHYL)ETHANOL; 1-(1-NAPHTHYL)ETHANOL |
| (+/-)-1-(1,2-Diphenylethyl)piperidine maleate | 36794-52-2 | C19H23N.C4H4O4 | 381.46 | (+/-)-1-(1,2-DIPHENYLETHYL)PIPERIDINE MALEATE |
| (+/-) N-TRANS[ETHOXY CARBONMETHYL]-1-PHENYLETHYLAMINE | 56720-98-0 | C12H17NO2 | 207.27 | (+/-) N-TRANS[ETHOXY CARBONMETHYL]-1-PHENYLETHYLAMINE |
| (+/-) Chlorosuccinic Acid | 617-41-4 | C4H5ClO4 | 0 | |
| (+/-) 3-ETHYL-3-(4-PYRIDINYL)-2,6-PIPERIDINEDIONE | 92788-10-8 | C12H14N2O2 | 218.25 | (+/-) 3-ETHYL-3-(4-PYRIDINYL)-2,6-PIPERIDINEDIONE; PYRIDOGLUTETHIMIDE; (+/-) 3-Ethyl-3-(4-pyridinyl)-2,6-piperidinedione (Pyridoglutethimide); 3-Ethyl-3-(4-pyridinyl)piperidine-2,6-dione; Pyridylglutarimide; 2,6-Piperidinedione, 3-ethyl-3- |
| (+)-U-50488 HYDROCHLORIDE | 107902-84-1 | C18H25Cl3N2O | 391.76 | (+)-TRANS-IR-2R-U-50488 HCL; (+)-U-50488HCl |
| (+)-TRANS-P-MENTH-2-ENE | 5113-93-9 | C10H18 | 138.25 | |
| (+)-TRANS-MYRTANOL | 132203-71-5 | C10H18O | 154.25 | (1R,2R)-10-PINANOL; (1R,2R)-6,6-DIMETHYLBICYCLO[3.1.1]HEPTANE-2-METHANOL; (+)-TRANS-MYRTANOL; (+)-TRANS-MYRTANOL, TERPENE STANDARD; MYRTANOL, -(-)-trans-(SG); (1R,2R)-10-Pinanol, (1R,2R)-6,6-Dimethylbicyclo[3.1.1]heptane-2-methanol |
| (+)-TRANS-LIMONENE 1,2-EPOXIDE | 6909-30-4 | C10H16O | 152.23 | (1S,2R,4R)-4-ISOPROPENYL-1-METHYL-1-CYCLOHEXENE 1,2-EPOXIDE; (1S,4R)-1,2-EPOXY-P-MENTH-8-ENE; (+)-TRANS-P-MENTHA-1,8-DIENE 1,2-EPOXIDE; (+)-TRANS-LIMONENE 1,2-EPOXIDE; (+)-trans-limonene oxide; (E)-Limonene oxide; Limonene oxide, trans-; trans-Limonen-1,2 |
| (+)-TRANS-HEPTACHLOREPOXIDE | 145213-12-3 | C10H5Cl7O | 389.319 | |
| (+)-Potassium DS-threo-isocitrate monobasic | 20226-99-7 | C6H7O7•K | 230.21 | |
| (+)-Podophyllotoxine | 77519-37-0 | C22H22O8 | 414.40500 | |
| (+)-P-MENTH-1-ENE | 1195-31-9 | C10H18 | 138.25 | R(+)-4-ISOPROPYL-1-METHYLCYCLOHEXENE; (+)-P-MENTH-1-ENE; (+)-1-Menthene; (+)-1-p-menthene; (+)-Carvomenthene; (R)-(+)-p-menth-1-ene; (R)-1-methyl-4-(1-methylethyl)cyclohexene; 4-Isopropyl-1-methyl-1-cyclohexene |
| (+)--Pinene | 19902-08-0 | 136.23 | (1R,5R)-2(10)-Pinene, (1R,5R)-6,6-Dimethyl-2-methylenebicyclo[3.1.1]heptane | |
| (+)-PERILLAALDEHYDE | 5503-12-8 | C10H14O | 150.22 | (4R)-4-(1-Methylethenyl)-1-cyclohexene-1-carboxaldehyde; (+)-Perillaldehyde; (R)-(+)-Perillaldehyde; (R)-4-(Prop-1-en-2-yl)cyclohex-1-ene-1-carboxaldehyde; |
| (+)-P-BROMOTETRAMISOLE OXALATE | 71461-24-0 | C11H11BrN2S.C2H2O4 | 373.2223 | (+)-6(4-BROMOPHENYL)-2,3,5,6-TETRAHYDROIMIDAZO[2,1-B]THIAZOLE ETHANEDIOATE OXALATE SALT; D-(+)-P-BROMOTETRAMISOLE OXALATE; D-P-BROMOTETRAMISOLE OXALATE; (+)-P-BROMOTETRAMISOLE OXALATE SALT; (+)-P-BROMOTETRAMISOLE OXALATE; (R)-(+) 4-BROMOTETRAMISOLE OXALAT |
| (+)-Pantothenic acid calcium salt hydrate | 305808-23-5 | 476.53 | ||
| (+)-O-ISOPROPYLIDENE-2,3-DIHYDROXY-1,4-BIS[BIS(4-TRIFLUOROMETHYLPHENYL)PHOSPHINO]BUTANE | 184095-64-5 | C35H28F12O2P2 | 770.52 | (-)-O-ISOPROPYLIDENE-2,3-DIHYDROXY-1,4-BIS[BIS(4-TRIFLUOROMETHYLPHENYL)PHOSPHINO]BUTANE; (+)-O-ISOPROPYLIDENE-2,3-DIHYDROXY-1,4-BIS[BIS(4-TRIFLUOROMETHYLPHENYL)PHOSPHINO]BUTANE |
| (+)-O-ISOPROPYLIDENE-2,3-DIHYDROXY-1,4-BIS[BIS(3,5-DIFLUOROMETHYLPHENYL)PHOSPHINO]BUTANE | 220196-30-5 | C39H24F24O2P2 | 1042.52 | (-)-O-ISOPROPYLIDENE-2,3-DIHYDROXY-1,4-BIS[BIS(3,5-DIFLUOROMETHYLPHENYL)PHOSPHINO]BUTANE; (+)-O-ISOPROPYLIDENE-2,3-DIHYDROXY-1,4-BIS[BIS(3,5-DIFLUOROMETHYLPHENYL)PHOSPHINO]BUTANE |
| (+)-O-ISOPROPYLIDENE-2,3-DIHYDROXY-1,4-BIS[BIS(2-METHYLPHENYL)PHOSPHINO]BUTANE | 85849-33-8 | C35H40O2P2 | 554.64 | (-)-O-ISOPROPYLIDENE-2,3-DIHYDROXY-1,4-BIS[BIS(2-METHYLPHENYL)PHOSPHINO]BUTANE; (+)-O-ISOPROPYLIDENE-2,3-DIHYDROXY-1,4-BIS[BIS(2-METHYLPHENYL)PHOSPHINO]BUTANE |
| (+)-Nicotine | 68935-27-3 | C10H14N2.C20H18O8 | 548.58 | (+)-Nicotine; (+)-Nicotine di-p-Toluoyl-D-tartrate salt |
| (+)-N-FORMYL-D-TERT-LEUCINE | 92571-59-0 | C7H13NO3 | 159.18 | (+)-N-FORMYL-3-METHYL-D-VALINE; (+)-N-FORMYL-D-TERT-LEUCINE; (+)-N-Formyl-3-methyl-D-valine~For-D-Tle-OH; (+)-N-FORMYL-D-TERT-LEUCINE 99+% |
| (+)-NEOMENARS | 83845-71-0 | C22H29As | 368.39 | (+)-NEOMENARS; (1S,2S,5R)-(+)-NEOMENTHYLDIPHENYLARSINE |
| (+)-N-BENZYL-N-METHYL-DINAPHTHO[2,1-D:1',2']DIOXAPHOSPHEPIN-4-AMINE, (11BS) | 490023-37-5 | C28H22NO2P | 435.45 | (S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A:3,4-A']DINAPHTHALEN-4-YL)BENZYL(METHYL)AMINE; (S)-(+)-BENZYL(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A:3,4-A']DINAPHTHALEN-4-YL)METHYLAMINE; (+)-N-BENZYL-N-METHYL-DINAPHTHO[2,1-D:1',2']DIOXAPHOSPHEPIN-4-AMINE, (11B |
| (+)-N-BENZYL-D-MALIMIDE | 165657-63-6 | C11H11NO3 | 205.21 | (R)-2-HYDROXY-N-BENZYLSUCCINIMIDE; (R)-1-BENZYL-3-HYDROXYPYRROLE-2,5-DIONE; (+)-N-BENZYL-D-MALIMIDE |
| (+)-N-Benzenesulfonylglutamic acid | 20531-37-7 | C11H13NO6S | 287.28902;g/mol | 20531-36-6;20531-37-7;(+)-N-Benzenesulfonylglutamicacid;AC1LXZ5A;SCHEMBL698930;CTK1A1549 |
| (+)-METHYL (3S)-5-[(TERT-BUTYLDIMETHYLSILYL)OXY]-3-HYDROXY-2,2-DIMETHYLPENTANOATE | 263900-32-9 | C13H28O4Si | 276.44 | (+)-METHYL (3S)-5-[(TERT-BUTYLDIMETHYLSILYL)OXY]-3-HYDROXY-2,2-DIMETHYLPENTANOATE |
| (+)-MENTHOFURAN | 17957-94-7 | C10H14O | 150.22 | (R)-3,6-DIMETHYL-4,5,6,7-TETRAHYDROBENZOFURAN; (+)-MENTHOFURAN; (+)-MENTHOFURAN, TERPENE STANDARD; (R)-(+)-MENTHOFURAN |
| (+)-McN 5652, (-)-di-O-toluyltartrate salt | 103729-16-4 | C19H21NSC20H18O8 | 0 | Pyrrolo[2,1-a]isoquinoline, 1,2,3,5,6,10b-hexahydro-6-[4-(methylthio)phenyl]-, (6S,10bR)-,; Pyrrolo[2,1-a]isoquinoline, 1,2,3,5,6,10b-hexahydro-6-[4-(methylthio)phenyl]-, (6S,10bR)-, (2R,3R)-2,3-di-(O-4-methylphenyloxy)butanedioate |
| (+)-ISOPULEGOL | 104870-56-6 | C10H18O | 154.25 | (1S,2R,5S)-2-ISOPROPENYL-5-METHYLCYCLOHEXANOL; (1S,3S,4R)-P-MENTH-8-EN-3-OL; (+)-ISOPULEGOL; terpenestandard; (1S,3S,4R)-p-Menth-8-en-3-ol, (1S,2R,5S)-2-Isopropenyl-5-methylcyclohexanol |
| (+)-ISOPINOCAMPHEOL | 27779-29-9 | C10H18O | 154.25 | 3-Pinanol, stereoisomer; 3-PINANOL; (+)-ISOPINOCAMPHEOL; ISOPINOCAMPHEOL, (+)-; (1s,2s,3s,5r)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-ol; ISOPINOCAMPHEOL, (-)-(SG); (1S,2S,3S,5R)-3-Pinanol, 3-Pinanol, (1S,2S,3S,5R)-2,6,6-Trimethylbicyclo[3.1.1]heptan-3-ol |
| (+)-Ipc2B(allyl)borane solution | 106356-53-0 | 326.37 | (+)-B-Allyldiisopinocampheylborane solution | |
| (+)-HIMBACINE | 6879-74-9 | C22H35NO2 | 345.52 | (+)-HIMBACINE; HIMBACINE; (3s-(3-alpha,3a-alpha,4-beta(1e,2(2r*,6s*)),4a-beta,8a-alpha,9a-yl)-3-methyl; naphtho(2,3-c)furan-1(3h)-one,decahydro-4-(2-(1,6-dimethyl-2-piperidinyl)ethen; (3s,3ar,4r,4as,8ar,9as)-4-[(1e)-2-[(2r,6s)-1,6-dimethyl-2-piperdinyl]et |
| (+)-Garcinia acid | 27750-13-6 | 190.11 | ()-Hydroxycitric acid lactone, (2S,3S)-3-Hydroxy-5-oxotetrahydrofuran-2,3-dicarboxylic acid, Garcinia lactone | |
| (+)-FMeMcN 5652, (+)-di-O-toluyltartrate salt | 432038-21-6 | C19H20FNSC20H18O8 | 0 | (+)-FMeMcN 5652, (+)-di-O-toluyltartrate salt; Pyrrolo[2,1-a]isoquinoline, 6-[4-[(fluoromethyl)thio]-phenyl]-1,2,3,5,6,10b-hexahydro-, (6S,10bR)-,; (+)-Fluoromethyl-McN 5652; Pyrrolo[2,1-a]isoquinoline, 6-[4-[(fluoromethyl)thio]-phenyl]-1,2,3,5,6,10b-hexa |
| (+)-EMETINE DIHYDROCHLORIDE HYDRATE 97 | 313222-95-6 | C29H40N2O42HCl | 571.57606;g/mol | (2R,3S,11bR)-2-[[(1S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine; hydrate; dihydrochloride; (+)-Emetinedihydrochloridehydrate; 313222-95-6 |
| (+-)-Duloxetine | 116539-58-3 | C18H19NOS | 297.41456;g/mol | CHEMBL424660; CHEBI:36796; ZEUITGRIYCTCEM-UHFFFAOYSA-N; N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine; 116817-13-1; LY227942 |
| (+-)-Duloxetine | 116817-13-1 | |||
| (+)-DIOP | 37002-48-5 | C31H32O2P2 | 498.53 | (S,S)-DIOP; (+)-O-ISOPROPYLIDENE-2,3-DIHYDROXY-1,4-BIS(DIPHENYLPHOSPHINO)BUTANE; (+)-1,4-BIS(DIPHENYLPHOSPHINO)-1,4-DIDEOXY-2,3-O-ISOPROPYLIDENE-D-THREITOL; (2S,3S)-(+)-1,4-BIS(DIPHENYLPHOSPHINO)-2,3-O-ISOPROPYLIDENE-2,3-BUTANEDIOL; (2S,3S)-(+)-2,3-O-ISOP |
| (+)-DihydroCarvone | 5524-05-0 | C10H16O | 152.23 | (+)-dihydrocarvone,mixtureofisomers; (2theta-trans)-cyclohexanon; 2-methyl-5-(1-methylethenyl)-,(2R-trans)-Cyclohexanone; Carvone,dihydro-; Cyclohexanone,2-methyl-5-(1-methylethenyl)-,(2R,5R)-rel-; Cyclohexanone,2-methyl-5-(1-methylethenyl)-,trans-; p-Men |
| (+)-DIHYDROCARVONE | 5948-04-9 | C10H16O | 152.23 | p-Menth-8-en-2-one, E-; P-MENTH-8-EN-2-ONE; (2R,5R)-5-ISOPROPENYL-2-METHYLCYCLOHEXANONE; D-DIHYDROCARVONE; (+)-DIHYDROCARVONE; DIHYDROCARVONE; DIHYDROCARVONE, (+)-; FEMA 3565 |
| (+)-Dibutyl-L-tartrate | 87-92-3 | C12H22O6 | 262.30 | (+)-Dibutyl-L-tartrate; L-(+)-Tartaric acid dibutyl ester |
| (+)-DIBENZOYL-L-TARTARIC ANHYDRIDE | 17637-11-5 | C18H12O7 | 340.28 | O,O-DIBENZOYL-L-TARTARIC ANHYDRIDE; (+)-DIBENZOYL-L-TARTARIC ANHYDRIDE; tartaric anhydride dibenzoate; O,O-DIBENZOYL-L-TARTARIC ANHYDRIDE, 98; Einecs 241-621-9 |
| (+)-Dibenzoyl-L-tartaric anhydride | 64339-95-3 | C18H12O7 | 340.29 | |
| (+)-Desmethyl-Rolipram | 347148-59-8 | C15H19NO3 | 0 | (+)-Desmethyl-Rolipram; 2-Pyrrolidinone, 4-[3-(cyclopentyloxy)-4-hydroxyphenyl]-, (4R)-; R-Desmethyl-Rolipram |
| (+)-CP 47,497 | 134308-14-8 | |||
| (+)-Corlumidine | 25344-54-1 | C2OH19NO6 | 369.37 | (6R)-6-[(1S)-7-hydroxy-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]-6H-furo[3,4-g][1,3]benzodioxol-8-one; (+)-Corlumidine; 25344-54-1; SCHEMBL12363726 |
| (+)-Corey lactone 5-(4-phenylbenzoate) | 39265-57-1 | C21H20O5 | 352.38 | (3aR,4S,5R,6aS)-(-)-Hexahydro-4-(hydroxymethyl)-2-oxo-2H-cyclopenta[b]furan-5-yl 1,1'-biphenyl-4-carboxylate; (+)-COREY LACTONE, 4-PHENYLBENZOATE ALCOHOL; (3aS,4R,5S,6aR)-(+)-Hexahydro-4-(hydroxymethyl)-5-(4-phenylbenzoyloxy)cyclopenta[b]-furan-2-one; (3a |
| (+-)-Colchicine | 54192-66-4 | |||
| (+)-cis-Heptachlorepoxide | 66429-34-3 | C10H5Cl7O | 389.32 | |
| (+-)-cis-5,6-Epoxy-5,6-dihydroquinoline N-oxide | 142044-38-0 | C9H7NO2 | ||
| (+)-CIS-2(S),3(S)-2,3-DIHYDROXY-2,3-DIHYDROIODOBENZENE | 138769-92-3 | C6H7IO2 | 238.02 | CIS-(1S,2S)-3-IODO-3,5,CYCLOHEXADIENE-1,2- DIOL; (+)-CIS-2(S),3(S)-2,3-DIHYDROXY-2,3-DIHYDROIODOBENZENE |
| (+)-cis-2-(S),3-(S)-2,3-dihydroxy-2,3-dihydrochlorobenzene | 65986-73-4 | C6H7ClO2 | 146.57 | (1S-CIS)-3-CHLORO-3,5-CYCLOHEXADIENE-1,2-DIOL; (+)-CIS-2(S),3(S)-2,3-DIHYDROXY-2,3-DIHYDROCHLOROBENZENE; CIS-(1S,2S)-3-CHLORO-3,5-CYCLOHEXADIENE-1,2- DIOL; (1S-CIS)-3-CHLORO-3 5-CYCLOHEXADIENE-1 & |
| (+)-CIS-2(R),3(S)-2,3-DIHYDROXY-2,3-DIHYDROBENZONITRILE ACETONIDE | 150767-96-7 | C10H11NO2 | 177.2 | (+)-CIS-2(R),3(S)-2,3-DIHYDROXY-2,3-DIHYDROBENZONITRILE ACETONIDE |
| (+)-CIS-2(R),3(S)-2,3-DIHYDROXY-2,3-DIHYDROBENZONITRILE | 138769-96-7 | C7H7NO2 | 137.14 | CIS-(1S,2R)-3-CYANO-3,5-CYCLOHEXADIENE-1,2- DIOL; (+)-CIS-2(R),3(S)-2,3-DIHYDROXY-2,3-DIHYDROBENZONITRILE |
| (+)-CHLOROMETHYL ISOMENTHYL ETHER | 26127-08-2 | C11H21ClO | 204.74 | (+)-CHLOROMETHYL ISOMENTHYL ETHER; (-)-CHLOROMETHYL MENTHYL ETHER |
| (+)-CHIRACAMPHOX | 155323-17-4 | C11H17N1O2 | 195.26 | (5S)-6,6-DIMETHYL-7,10-METHYLEN-3-OXA-1-AZASPIRO[4.5]DECAN-2-ONE; (+)-CHIRACAMPHOX; (5S)-6,6-DIMETHYL-7,10-METHYLEN-3-OXA-1- AZASPIRO-DECAN-2-ONE |
| (+)-Camphene | 565-00-4 | C10H16 | 136.23 | 2-dimethyl-3-methylene-(+/-)-bicyclo[2.2.1]heptan; FEMA 2229; D,L-CAMPHENE; CAMPHENE 90; CAMPHENE 46; AKOS NCG1-0107; Camphene (contains ca 20% trycyclene); containsca20%richcyclene |
| (+)-Camphene | 5794-03-6 | 136.23 | (1R)-2,2-Dimethyl-3-methylenebicyclo[2.2.1]heptane | |
| (+)-butaclamol hydrochloride | 55528-07-9 | C25H32ClNO | 397.98 | (+)-BUTACLAMOL HYDROCHLORIDE; (+)-BUTACLAMOL HYDROCHLORIDE DOPAMINE AN TAGONIST |
| (+)-Butaclamol | 56245-67-1 | C25H31NO | 361.51974;g/mol | (+)-Butaclamol;d-Butaclamol;BUTACLAMOL;CHEMBL8514;Butaclamolum;1H-Benzo(6,7)cyclohepta(1,2,3-de)pyrido(2,1-a)isoquinolin-3-ol,2,3,4,4a,8,9,13b,14-octahydro-3-(1,1-dimethylethyl)-,(3S-(3-alpha,4a-alpha,13b-beta))- |
| (+)-Biotin azidopropylamide | 908007-17-0 | C13H22N6O2S | 326.42 | |
| (+)-Bicifadine Hydrochloride | 66504-82-3 | C12H16ClN | 209.72 | (1R,5S)-1-(4-Methylphenyl)- |
| (+)-Benzotetramisole | 885051-07-0 | C15H12N2S | 252.33 | (+)-BTM |
| (+)-Allylboronic acid pinanediol ester | 77091-61-3 | C13H21BO2 | 220.11600 | |
| (+)-AJ 76 HYDROCHLORIDE | 85379-09-5 | C15H24ClNO | 269.81 | AJ-76; (+)-AJ76 HCL; (+)-AJ 76 HYDROCHLORIDE; (1S,2R)-CIS-5-METHOXY-1-METHYL-2-(N-PROPYLAMINO)-TETRALIN HCL; (1S,2R)-CIS-5-METHOXY-1-METHYL-2-(N-PROPYLAMINO)TETRALIN HYDROCHLORIDE; (1S,2R)-cis-5-Methoxy-1-methyl-2-(N-propylamino)tetralinehydrochloride; 5- |
| (+)-8(15)-CEDREN-9-OL | 13567-41-4 | C15H24O | 220.35 | (+)-8(15)-CEDREN-9-OL; (1R,2R,5S,7R,9S)-8-METHYLENE-2,6,6-TRIMETHYLTRICYCLO[5.3.1.0(1.5)]UNDECAN-9-OL |
| (+)-7-Octylindolactam v | 123597-54-6 | C25H39N3O2 | 0 | |
| (+-)-5-Hydroxytryptophan | 72572-98-6 | C11H12N2O3 | ||
| (+)-5,6-O-CYCLOHEXYLIDENE-L-ASCORBIC ACID | 6614-52-4 | C12H16O6 | 256.25 | (+)-5,6-O-CYCLOHEXYLIDENE-L-ASCORBIC ACID; (+)-5 6-O-CYCLOHEXYLIDENE-L-ASCORBIC & |
| (+)-4'-METHYLTARTRANILIC ACID | 206761-79-7 | C11H13NO5 | 239.22 | (+)-4'-METHYLTARTRANILIC ACID |
| (+)-4'-FLUOROTARTRANILIC ACID | 206761-65-1 | C10H10FNO5 | 243.19 | (+)-4'-FLUOROTARTRANILIC ACID; (+)-4-FLUOROTARTRANILIC ACID; (+)-4'-FLUOROTARTANILIC ACID; (+)-4'-Fluorotartanilicacid97% |
| (+)-3-HYDROXYLAMINO ISOBORNEOL HYDROCHLORIDE, 97 | 162425-96-9 | C10H20ClNO2 | 221.7243 | (+)-3-HYDROXYLAMINO ISOBORNEOL HYDROCHLORIDE, 97; (+)-3-HydroxylaminoisoborneolHCl |
| (+)-3-Carboxy-2,2,5,5-tetramethylpyrrolidinyl-1-oxy | 50525-83-2 | C9H17NO3 | 187.24 | R-(+)-3-Carboxy-2,2,5,5-tetramethyl-1-pyrrolidinyloxy; (+)-3-Carboxy-PROXYL |
| (+)-3,9-DIBROMOCAMPHOR | 10293-10-4 | C10H14Br2O | 310.03 | (+)-3,9-DIBROMOCAMPHOR; 3,9-DIBROMO-(+)-CAMPHOR |
| (+)-2-O-BENZYL-L-THREITOL | 84379-53-3 | C11H16O4 | 212.24 | (2S,3S)-3-BENZYLOXY-BUTANE-1,2,4-TRIOL; (2S,3S)-(+)-2-BENZYLOXY-1,3,4-BUTANETRIOL; (+)-2-O-BENZYL-L-THREITOL; 2-BENZYLOXY-2-(2,2-DIMETHYL-[1,3]DIOXOLAN-4-YL)-ETHANOL |
| (+)-2-O-BENZYL-L-THREITOL | 84379-51-1 | C11H16O4 | 212.24 | (2S,3S)-3-BENZYLOXY-BUTANE-1,2,4-TRIOL; (2S,3S)-(+)-2-BENZYLOXY-1,3,4-BUTANETRIOL; (+)-2-O-BENZYL-L-THREITOL; 2-benzyloxy-1,3,4-butanetriol |
| (+)-2-Methylbutyl p-aminocinnamate | 62742-50-1 | C14H19NO2 | 233.30616 | (+)-2-Methylbutyl p-aminocinnamate; (R)-(E)]-3-(4-AMINOPHENYL)-2-PROPENOIC ACID 2-METHYLBUTYL ESTER; 3-(4-Aminophenyl)propenoic acid (R)-2-methylbutyl ester; (2R)-(+)-2-Methylbutyl p-aminocinnamate,98% |
| (+)-2-CARENE | 4497-92-1 | C10H16 | 136.23 | (1S)-(+)-car-2-ene; 7,7-trimethyl-(1s-cis)-bicyclo[4.1.0]hept-2-en; bicyclo[4.1.0]hept-2-ene,3,7,7-trimethyl-,(1S-cis)-; (+)-2-CARENE; (1S)-3,7,7-TRIMETHYLBICYCLO[4.1.0]HEPT-2-ENE; (1S-CIS)-2-CARENE; CARENE, (1S-CIS)-2-; (1S-cis)-3,7,7-trimethylbicyclo[4. |
| (+-)-2-Aminohexane-1,1,1,2,3,3-d6 | 5329-79-3 | CH3CH2CH2CD2CD(NH2)CD3 | 107.23 | |
| (+)-2,3-O-Benzylidene-D-threitol | 58383-35-0 | C11H14O4 | 210.23 | (+)-2,3-O-BENZYLIDENE-D-THREITOL; (4R,5R)-(+)-2-PHENYL-1,3-DIOXOLANE-4,5-DIMETHANOL; 1,3-Dioxolane-4,5-dimethanol, 2-phenyl-, (4R,5R)-; (+)-2,3-O-BENZYLIDENE-D-THREITOL 98+% |
| (+)-2,2-Methylenebis[(3aR,8aS)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole] | 180186-94-1 | C21H18N2O2 | 330.38 | |
| (+)-2,2'-Isopropylidenebis[(4R)-4-phenyl-2-oxazoline] | 150529-93-4 | C21H22N2O2 | 334.41 | (R)-(+)-2,2'-ISOPROPYLIDENEBIS(4-PHENYL-2-OXAZOLINE); (R,R)-2,2-BIS(4-PHENYL-2-OXAZOLIN-2-YL)PROPANE; (R,R)-2,2'-(DIMETHYLMETHYLENE)BIS(4-PHENYL-2-OXAZOLINE); (R,R)-2,2'-ISOPROPYLIDENEBIS(4-PHENYL-2-OXAZOLINE); (+)-2,2'-isopropylidenebis[(4r)-4-phenyl-2-o |
| (+)-2-(2,2-dicyclohexylethyl)piperidine | 39648-48-1 | C19H35N | 277.4879 | (+)-2-(2,2-dicyclohexylethyl)piperidine |
| (+)-2 2'-ISOPROPYLIDENEBIS((4R)-4-BENZYL | 141362-77-8 | C23H26N2O2 | 362.46 | (+)-2 2'-ISOPROPYLIDENEBIS((4R)-4-BENZYL; (R(R*,R*))-(+)-2,2'-(isopropylidenebis(4-benzyl-2; (R(R*,R*))-(+)-2,2'-(ISOPROPYLIDENEBIS(4; (+)-2,2'-isopropylidenebis[(4r)-4-benzyl-2-oxazoline]; (r,r)-(+)-2,2'-isopropylidenebis(4-benzyl-2-oxazoline); [R(R*,R*) |
| (+-)-13-AZAPROSTANOIC ACID | 71629-07-7 | C19H37NO2 | 0 | trans-7-(2-[Heptylamino]cyclopentane)heptanoic acid |
| (+)-10-CAMPHORSULFONIMINE | 107869-45-4 | C10H15NO2S | 213.3 | (1R)-(+)-CAMPHORSULFONYLIMINE; (1R)-(+)-(10-CAMPHORSULFONYL)IMINE; (+)-10-CAMPHORSULFONIMINE; (3AR)-(+)-4,5,6,7-TETRAHYDRO-8,8-DIMETHYL-3H-3A,6-METHANO-2,1-BENZISOTHIAZOLE 2,2-DIOXIDE; (3AR)-4,5,6,7-TETRAHYDRO-8,8-DIMETHYL-3H-3A,6-METHANO-2,1-BENZISOTHIAZ |
| (+)-1,3,4,14b-Tetrahydro-2,7-dimethyl-2H-dibenzo(b,f)pyrazino(1,2-d)oxazepine maleate | 85391-77-1 | 396.43636 | ||
| (+)-1,2-Dioleoylglycerol (18:1) | 3738-74-7 | C39H72O5 | 620.99 | (+)-1,2-Dioleoylglycerol (18:1); (+/-)-Dioleoylglycerol |
| (+)-1,2-BIS[(2S,5S)-2,5-DIMETHYLPHOSPHOLANO]BENZENE | 136735-95-0 | C18H28P2 | 306.36 | (S,S)-ME-DUPHOS; (S,S)-METHYL-DUPHOS; (+)-1,2-BIS[(2S,5S)-2,5-DIMETHYLPHOSPHOLANO]BENZENE; (2S,2'S,5S,5'S)-2,2',5,5'-TETRAMETHYL-1,1'-(1,2-PHENYLENE)DIPHOSPHOLANE; (2S,2'S,5S,5'S)-2,2',5,5'-TETRAMETHYL-1,1'-(O-PHENYLENE)DIPHOSPHOLANE; (+)-1,2-Bis((2S,5S)- |
| (+)-1,2-BIS[(2S,5S)-2,5-DIETHYLPHOSPHOLANO]BENZENE | 136779-28-7 | C22H36P2 | 362.47 | (S,S)-ETHYL-DUPHOS; (S,S)-ET-DUPHOS; (2S,2'S,5S,5'S)-2,2',5,5'-TETRAETHYL-1,1'-(1,2-PHENYLENE)DIPHOSPHOLANE; (2S,2'S,5S,5'S)-2,2',5,5'-TETRAETHYL-1,1'-(O-PHENYLENE)DIPHOSPHOLANE; (+)-1,2-BIS[(2S,5S)-2,5-DIETHYLPHOSPHOLANO]BENZENE; (+)-1,2-Bis[(2S,5S)-2,5- |
| (+)-1,2-BIS((2S,5S)-2,5-DIMETHYLPHOSPHOLANO)BENZENE(CYCLOOCTADIENE)RHODIUM(I)TETRAFLUOROBORATE | 205064-10-4 | C26H40BF4P2Rh 4* | 604.25 | (+)-1,2-BIS((2S,5S)-2,5-DIMETHYLPHOSPHOLANO)BENZENE(CYCLOOCTADIENE)RHODIUM(I)TETRAFLUOROBORATE; (+)-1,2-BIS((2S,5S)-DIMETHYLPHOSPHOLANO)BENZENE(CYCLOOCTADIENE)RHODIUM(I) BF4; (+)-1,2-Bis((2S,5S)-2,5-dimethylphospholano)benzene(cyclooctadiene)rhodium(l)tet |
| (-)-MENPHOS | 43077-31-2 | C22H29P | 324.44 | (1R,2S,5R)-(-)-MENTHYLDIPHENYLPHOSPHINE; (-)-MENPHOS |
| (-)-McN 5652, (+)-di-O-toluyltartrate salt | 103729-13-1 | C19H21NSC20H18O8 | 0 | (-)-McN 5652, (+)-di-O-toluyltartrate salt; Pyrrolo[2,1-a]isoquinoline, 1,2,3,5,6,10b-hexahydro-6-[4-(methylthio)phenyl]-, (6R,10bS)-,; Pyrrolo[2,1-a]isoquinoline, 1,2,3,5,6,10b-hexahydro-6-[4-(methylthio)phenyl]-, (6R,10bS)-, (2S,3S)-2,3-di-(O-4-methylph |
| (-)-Limonene | 5989-54-8 | C10H16 | 136.23 | (-)-1,8-p-menthadiene,(S)-(-)-limonene; (S)-(-)-1-methyl-4-(1-methylethenyl)cyclohexene; (s)-(-)-p-mentha-1,8-diene; (s)-(-)-p-mentha-8-diene; (s)-1-methyl-4-(1-methylethenyl)cyclohexene; (s)-cyclohexen; 1-methyl-4-(1-methylethenyl)-,(S)-Cyclohexene; beta |
| (+)-1,2-BIS((2R,5R)-2,5-DIETHYLPHOSPHOLANO)ETHANE | 136705-62-9 | C18H36P2 | 314.43 | (+)-1,2-BIS((2R,5R)-2,5-DIETHYLPHOSPHOLANO)ETHANE; (R,R)-ET-BPE; Bisdiethylphospholanoethane; (+)-1,2-Bis[(2R,5R)-2,5-diethylphospholano]ethane, Kanata purity; (+)-1,2-Bis((2R,5R)-2,5-diethylphospholano)ethane,98+%(R,R)-Et-BPE |
| (+)-1,1'-bis-((2R,4R)-2,4-Diethylphosphotano)ferrocene(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate | 268220-96-8 | C32H48BF4FeP2Rh | 740.23 | (+)-1,1'-BIS(2R,4R)-(2,4-DIETHYLPHOSPHONATO)FERROCENE(1,5-CYCLOOCTADIENE)RHODIUM(I) TETRAFLUOROBORATE; (+)-1,1'-BIS((2R,4R)-2,4-DIETHYLPHOSPHOTANO)FERROCENE(1,5-CYCLOOCTADIENE)RHODIUM (I) TETRAFLUOROBORATE; (-)-1,1-Bis(2S,4S)-2,4-diethylphosphotano)ferroc |
| (+)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE | 118609-65-7 | C16H13ClO2 | 272.73 | (-)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE; (+)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE; (+)-FLEC(TM); (-)-FLEC(R); (+)-FLEC(R); (-)-FLEC |
| (+)-1-(9-Fluorenyl)ethyl chloroformate | 105764-39-4 | C16H13ClO2 | 272.73 | (-)-FLEC; (+)-FLEC; (-)-FLEC(R); (+)-FLEC(R); (+)-FLEC(TM); (-)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE |
| (+)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE | 154479-90-0 | C16H13ClO2 | 272.73 | (-)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE; (+)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE; (+)-FLEC(TM); (-)-FLEC; (+)-FLEC; (-)-FLEC(R) |
| (+)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE | 107474-79-3 | C16 H13 Cl O2 | 272.73 | (+)-FLEC SOLUTION,50 MG IN 10 ML ACETONE; (+)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE, 18MMOL SOLUTION IN ACETONE; (-)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE, 0.5W/V % SOLUTION IN ACETONE |
| (+)-1 4-di-o-tosyl-D-threitol | 50623-73-9 | C18H22O8S2 | 430.49 | (+)-1 4-DI-O-TOSYL-D-THREITOL; D-THREITOL 1,4-DI-P-TOSYLATE); (+)-1 4-DI-O-TOSYL-D-THREITOL 8%; Nsc126574 |
| (+)-(Z)-7-chloro-2-(2,2-dimethylcyclopropanecarboxamido)-2-heptenoic acid | 877674-77-6 | C13H20ClNO3 | 273.75600 | |
| (+)-(S)-L-alanine(S)-(+)-N-acetyl-L-alanine methyl ester | 869082-12-2 | |||
| ({5-[(2,6-Dimethylphenoxy)methyl]-4-phenyl-4H-1,2,4-triazol-3-yl}thio)acetic acid | 64013-61-2 | C19H19N3O3S | ||
| (+)-(S)-4-[4-[1-(4-chloroph-enyl)-1-(2-pyridyl)methoxy]pip-eridin-1-yl]butyric acid(bopotastine base) | 190786-43-7 | C21H25ClN2O3 | 388.89 | 4-(4-[(1S)(4-CHLOROPHENYL)-2-PYRIDYLMETHOXY]PIPERIDYL)BUTANOIC ACID |
| (+)-(5aR,10bS)-5a,10b-Dihydro-2-(2,4,6-trimethylphenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium ChlorideMonohydrate | 903571-02-8 | C21H22ClN3O.H2O | 385.89 | (+)-(5aR,10bS)-5a,10b-Dihydro-2-mesityl-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Chloride |
| (+)-(3AS,6AS)-3A,6A-DIHYDRO-2,2-DIMETHYL-4H-CYCLOPENTA-1,3-DIOXOL-4-ONE | 104010-72-2 | C8H10O3 | 154.16 | (+)-(3AS,6AS)-3A,6A-DIHYDRO-2,2-DIMETHYL-4H-CYCLOPENTA-1,3-DIOXOL-4-ONE |
| (+)-(3aR,4R,5r,6aS)-Hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-4-(3-trifluoromethyl)phenoxy-1-butenyl]-2H-cyclopenta[b]furan-2-one | 53872-60-9 | C18H19F3O5 | 372.34 | (+)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1E,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL]-2H-CYCLOPENTA[B]FURAN-2-ONE; (+)-FLUPROSTENOL LACTONE DIOL; (+)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1E,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BU |
| (+)-(2S,6Z,9S,10E)-9-{[tert-Butyl(dimethyl)silyl]oxy}-2,6,10-trimethyl-11-(2-methyl-1,3-thiazol-4-yl)-undeca-6,10-dien-1-ol | 210690-99-6 | C24H43NO2SSi2 | 437.75422 | (+)-(2S,6Z,9S,10E)-9-{[tert-Butyl(dimethyl)silyl]oxy}-2,6,10-trimethyl-11-(2-methyl-1,3-thiazol-4-yl)-undeca-6,10-dien-1-ol |
| (+)-(18-Crown-6)-2,3,11,12-tetracarboxylic acid | 61696-54-6 | C16H24O14 | 440.35 | (+)-(18-CROWN-6)-2,3,11,12-TETRACARBOXYLIC ACID; (2R,3R,11R,12R)-1,4,7,10,13,16-HEXAOXACYCLOOCTADECANE-2,3,11,12-TETRACARBOXYLIC ACID; (+)-(CROWN-6)-2,3,11,12-TETRACARBOXYLIC ACID; (+)-(18-Crown-6)-2,3,11,12-tetracarboxylic acid; C90001 |
| (+)-(18-Crown-6)-2,3,11,12-tetracarboxamide | 57207-22-4 | C24H44N4O10 | 436.41432 | (+)-(18-CROWN-6)-2,3,11,12-TETRACARBOXAMIDE |
| ([2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]SULFINYL)ACETIC ACID | 957372-02-0 | C9H6F3NO5S | 297.21 | ([2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]SULFINYL)ACETIC ACID; IFLAB-BB F1304-0055; CHEMBRDG-BB 6828231 |
| ([1,2,4]Triazolo[3,4-b][1,3]benzothiazol-3-ylthio)acetic acid | 114722-63-3 | C10H7N3O2S2 | 265.31 | AKOS BC-3151; ([1,2,4]TRIAZOLO[3,4-B][1,3]BENZOTHIAZOL-3-YLTHIO)ACETIC ACID; IFLAB-BB F0307-0305 |
| (-)-USNIC ACID | 6159-66-6 | C18H16O7 | 344.32 | (-)-USNEIN; (9bS)-2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl(2H,9bH)-dibenzofuran-1,3-dione; (-)-USNIC ACID 97%; (-)-USNEIN 97%; (9bS)-7,9-Dihydroxy-2,6-diacetyl-8,9b-dimethyldibenzofuran-1,3(2H,9bH)-dione; [9bS,(-)]-2,6-Diacetyl-7,9-dihydroxy-8,9b-dimethyl |
| (-)-U-50488 HYDROCHLORIDE | 133162-85-3 | C18H25Cl3N2O | 391.76 | trans-(1s,2s)-3,4-dichloro-n-methyl-n-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide hydrochloride |
| (-)-TROGER'S BASE | 14645-24-0 | C17H18N2 | 250.34 | (5S,11S)-(-)-2,8-DIMETHYL-6H,12H-5,11-METHANODIBENZO[B,F][1,5]DIAZOCIN; (-)-TROGER'S BASE; (S)-2,8-dimethyl-5,11-methanodibenzo (B,F)(1,5)diazocin |
| (-)-TRANS-MYRTANYL ACETATE | 90934-53-5 | C12H20O2 | 196.29 | (1S,2S)-6,6-DIMETHYLBICYCLO[3.1.1]HEPTANE-2-METHYL ACETATE; (-)-TRANS-MYRTANYL ACETATE; (-)-TRANS-MYRTANYL ACETATE, TERPENE STAN DARD |
| (-)-TRANS-CHLORDANE | 142433-24-7 | C10H6Cl8 | 409.781 | |
| ()-TRANS-10-HYDROXYNORTRIPTYLINE | 47132-16-1 | C19H21NO | 279.381 | ()-TRANS-10-HYDROXYNORTRIPTYLINE; (E)-10,11-Dihydro-5-(3-(methylamino)propylidene)-5H-dibenzo(A,D)cyclohepten-10-ol; 5H-Dibenzo(A,D)cyclohepten-10-ol, 10,11-dihydro-5-(3-(methylamino)propylidene)-, (E)- |
| (-)-Thysanone | 233279-24-8 | C14H12O6 | 276.24 | (1R,3S)- |
| (-)-TETRAPHOS | 54294-46-1 | C42H42P4 | 670.68 | (-)-TETRAPHOS; (4R,7R)-(-)-1,1,4,7,10,10-HEXAPHENYL-1,4,7,10-TETRAPHOSPHADECANE |
| (-)-TAN 2162 | 59785-91-0 | C32H61N13O9 | 771.91 | H-LEU-ARG-ARG-ALA-SER-VAL-ALA-OH; LEU-ARG-ARG-ALA-SER-VAL-ALA; LRRASVA; KEMPTIDE [LRRASVA], [VAL6, ALA7]; KENDOMYCIN; KENDOMYCIN, STREPTOMYCES VIOLACEORUBER; (-)-TAN 2162; (VAL6,ALA7)-KEMPTIDE |
| (-)-syn-Benzo(g)chrysene-11,12-dihydrodiol-13,14-epoxide | 119479-44-6 | C22H16O3 | 328.36064;g/mol | |
| (-)-PERILLIC ACID | 23635-14-5 | C10H14O2 | 0 | (S)-4-(1-Methylethenyl)-1-cyclohexene-1-carboxylic acid; (S)-4-Isopropenylcyclohexene-1-carboxylic acid; L(-)-Perillic acid,95% |
| (-)-Osu | 146798-66-5 | C15H23NO2S | 281.418 | (-)-OSU; (S)-3-[3-(Methylsulfonyl)phenyl]-1-propyl-piperidine; PNU 96391A |
| (-)-O-Acetyl-L-lactic aicd | 6034-46-4 | C5H8O4 | 132.11 | (-)-O-ACETYL-L-LACTIC ACID; (S)-A-2-ACETOXYPROPIONIC ACID; (S)-ACETYLLACTIC ACID; (S)-(-)-2-ACETOXYPROPIONIC ACID; (S)-ALPHA-ACETOXYPROPIONIC ACID; (-)-O-ACETYL-L-LACTIC AICD; Propanoic acid, 2-(acetyloxy)-, (2S)-; (-)-2-O-Acetyl-L-lactic acid |
| (-)-O,O'-Dibenzoyl-L-tartaric acid mono(dimethylamide) | 78761-37-2 | C20H19NO7 | 385.37 | |
| (-)-NICOTINE-[METHYL-3H] | 152558-62-8 | C10H13N2T | 164.24 | (-)-NICOTINE-[METHYL-3H]; (-)-[N-METHYL-3H]NICOTINE; (-)-nicotine-(N-methyl-3H) |
| ()-Neomenthol | 20747-49-3 | 156.27 | (1R,2R,5S)-2-Isopropyl-5-methylcyclohexanol | |
| (-)-N-[(4-METHYLPHENYL)SULFONYL]-D-GLUTAMINE | 883452-10-6 | C12H16N2O5S | 0 | |
| (-)-N-[(1-ethylpyrrolidin-2-yl)methyl]-6-methoxy-1H-benzotriazole-5-carboxamide dihydrochloride | 23519-20-2 | C15H23Cl2N5O2 | 376.28142 | (-)-N-[(1-ethylpyrrolidin-2-yl)methyl]-6-methoxy-1H-benzotriazole-5-carboxamide dihydrochloride |
| (-)-N,N-DIBENZYL-D-ALANINOL | 60479-64-3 | C17H21NO | 255.35 | (-)-N,N-DIBENZYL-D-ALANINOL; (R)-2-(DIBENZYLAMINO)-1-PROPANOL; (R)-2-(DIBENZYLAMINO)PROPAN-1-OL; 2-(R)-DIBENZYLAMINOPROPAN-1-OL |
| (-)-N,N'-(1R,2R)-1,2-DIAMINOCYCLOHEXANEDIYLBIS(2-PYRIDINECARBOXAMIDE) | 218290-24-5 | C18H20N4O2 | 324.38 | (-)-N,N'-(1R,2R)-1,2-DIAMINOCYCLOHEXANEDIYLBIS(2-PYRIDINECARBOXAMIDE); Diaminocyclohexanediylbispyridinecarboxamide; (1R,2R)-1,2-Bis(2-pyridinecarboxamido)cyclohexane; (-)-N,N'-(1R,2R)-1,2-Diaminocyclohexanediylbis(2-pyridinecarboxamide),min.98%; (-)-N,N' |
| (-)-Mod diop | 127797-02-8 | C43H56 O6 P2 | 0 | (-)-MOD-DIOP |
| (-)-Mequitazine | 88598-74-7 | C20H22N2S | 322.47 | |
| (-)-LEUKOTRIENE A4 METHYL ESTER | 73466-12-3 | C21H32O3 | 332.48 | (-)-LEUKOTRIENE A4 METHYL ESTER; LEUKOTRIENE A4 METHYL ESTER; 5S-TRANS-5,6-OXIDO-7E,9E,11Z,14Z-EICOSATETRAENOIC ACID, METHYL ESTER; (-)-leukotriene A4; LEUKOTRIENE A4-METHYLESTER SOLUTION (100UG/ML HEXANE/1% TRIETHYLAMINE) |
| (-)-Isosativene | 24959-83-9 | C15H24 | 204.35 | (-)-ISOSATIVENE |
| (-)-ISOPROTERENOL HYDROCHLORIDE | 5984-95-2 | C11H18ClNO3 | 247.72 | (r)-isoprenalinehydrochloride; (r)-isoproterenolhydrochloride; 1,2-benzenediol,4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-,hydrochloride,; benzylalcohol,3,4-dihydroxy-alpha-((isopropylamino)methyl)-,hydrochloride,(; l-isoprenalinechloride; l-isoprenaline |
| ()-Isoproterenol (+)-bitartrate salt | 54750-10-6 | 361.34 | ()-Isoprenaline (+)-bitartrate salt | |
| (-)-ISOPINOCAMPHEYLAMINE | 69460-11-3 | C10H19N | 153.26 | (-)-ISOPINOCAMPHEYLAMINE; (1R,2R,3R,5S)-(-)-ISOPINOCAMPHEYLAMINE; (1R,2R,3R,5S)-3-PINANAMINE; (1R,2R,3R,5S)-(-)-ISOPINOCAMPHEYLAMINE,95%; (-)-Isopinocampheylamine, (1R,2R,3R,5S)-3-Pinanamine |
| (-)-IsopinoCampheol | 25465-65-0 | C10H18O | 154.25 | (-)-ISOPINOCAMPHEOL; ISOPINOCAMPHEOL, (-)-; (-)3-PINANOL; 3-PINANOL; (1R,2R,3R,5S)-2,6,6-TRIMETHYL-BICYCLO[3.1.1]HEPTAN-3-OL; (1R,2R,3R,5S)-3-PINANOL; (1R,2R,3R,5S)-(-)-ISOPINOCAMPHEOL; (-)-pinan-3-ol |
| (-)-ISOPINOCAMPHENYLBORANE TMEDA COMPLEX | 67826-92-0 | C26H54B2N2 | 416.34 | (-)-ISOPINOCAMPHENYLBORANE TMEDA COMPLEX; (-)-N,N'-BIS(MONOISOPINOCAMPHENYLBORANE)-N,N,N',N'-TETRAMETHYLETHYLENEDIAMINE; N,N'-BIS(MONOISOPINOCAMPHEYL-BORANE)-N,N,N',N'-TETRAMETHYLETHYLENEDIAMINE; R-ALPINE-BORAMINE(TM); R-alpine-boramine; (R)-Alpine-Borami |
| (-)-Isolongifolol | 1139-17-9 | C15H26O | 222.37 | (1S,11S)-3,3,7-TRIMETHYLTRICYCLO[5.3.1.0(2.8)]UNDECANE-11-METHANOL; (-)-ISOLONGIFOLOL; ISOLONGIFOLOL, (-); [1S-(1alpha,3abeta,4alpha,8abeta,9R*)]-decahydro-4,8,8-trimethyl-1,4-methanoazulene-9-methanol; ISOLONGIFOLOL, (-)-(SG); (-)-ISOLONGIFOLOL WITH GC; |
| (-)-ISOCARYOPHYLLENE | 118-65-0 | C15H24 | 204.35 | (1r-(1r*,4z,9s*))-4,11,11-trimethyl-8-methylenebicyclo(7.2.0)undec-4-ene; (1r-(1r,4z,9s))-4,11,11-trimethyl; (1r-(1r,4z,9s))-4,11,11-trimethyl-8-methylenebicyclo(7.2.0)undec-4-ene; (Z)-beta-caryophyllene; ,9s)]-; 4,11,11-trimethyl-8-methylene-,[1R-(1R*,4Z |
| (-)-HYDROXYMATAIRESINOL | 20268-71-7 | C20H22O7 | 374.38 | HMR 2; (-)-HYDROXYMATAIRESINOL |
| (-)-HYDROXYMATAIRESINOL | 81623-30-5 | C20H22O7 | 374.38 | HMR 2; (-)-HYDROXYMATAIRESINOL |
| (-)-ETHYL (R)-2-HYDROXY-4-OXO-4-PHENYLBU | 244277-48-3 | C12H14O4 | 222.24 | |
| (-)-Esphos ligand | 254990-08-4 | C16H24N4P2 | 334.342 | (3aS)-1-[2-[(3aS)-2,3,3a,4,5,6-hexahydropyrrolo[1,2-c][1,3,2]diazaphosphol-1-yl]phenyl]-2,3,3a,4,5,6-hexahydropyrrolo[1,2-c][1,3,2]diazaphosphole; (-)-Esphosligand; ZINC86860349; FT-0604393; 254990-08-4 |
| (-)-EPIGALLOCATECHIN 3-(4''-O-METHYL)GALLATE | 224434-07-5 | C23H20O11 | 472.4 | (-)-EPIGALLOCATECHIN 3-(4''-O-METHYL)GALLATE |
| (-)-EPICEDROL | 19903-73-2 | C15H26O | 222.37 | (-)-EPICEDROL; EPICEDROL,(-)-; (1R,2R,5S,7R,8R)-2,6,6,8-TETRAMETHYL-TRICYCLO[5.3.1.0(1.5)]UNDECAN-8-OL |
| (-)-EGCG-4'-O-ME | 298700-57-9 | C23H20O11 | 472.4 | (-)-EGCG-4'-O-ME; (-)-EPIGALLOCATECHIN-4'-O-METHYL ETHER GALLATE |
| (-)-EGCG-3'-O-ME | 298700-56-8 | C23H20O11 | 472.4 | (-)-EPIGALLOCATECHIN-3'-O-METHYL ETHER GALLATE; (-)-EGCG-3'-O-ME |
| (-)-ECG-4''-O-ME | 108907-44-4 | C23H20O10 | 456.4 | (-)-EPICATECHIN 3-(4''-O-METHYL)GALLATE; (-)-ECG-4''-O-ME |
| (-)-Diisopropyl-L-malate | 83541-68-8 | C10H18O5 | 218.24 | L-MALIC ACID DIISOPROPYL ESTER; DIISOPROPYL (S)-(-)-MALATE; (-)-DIISOPROPYL-L-MALATE; DIISOPROPYL L-MALATE; (S)-2-Hydroxybutanedioic acid diisopropyl ester; (S)-2-Hydroxysuccinic acid diisopropyl ester; [S,(-)]-2-Hydroxysuccinic acid diisopropyl ester |
| (-)-DIHYDROCARVYL ACETATE | 75684-65-0 | C12H20O2 | 196.29 | L-DIHYDROCARVYL ACETATE; FEMA 2380; DIHYDROCARVEYL ACETATE; (-)-DIHYDROCARVYL ACETATE; (+)-DIHYDROCARVYLACETATE; DIHYDROCARVYL ACETATE; DIHYDROCARVYLACETATE, (-)-; DIHYDROCARVYLACETATE, (+)- |
| (-)-Desmethyl-Rolipram | 347148-60-1 | C15H19NO3 | 0 | 2-Pyrrolidinone, 4-[3-(cyclopentyloxy)-4-hydroxyphenyl]-, (4S)-; S-Desmethyl-Rolipram |
| (-)-CYDIOP | 82239-68-7 | C31H56O2P2 | 522.72 | (-)-CYDIOP; (4S,5S)-BIS[(DICYCLOHEXYLPHOSPHINO)METHYL]-2,2-DIMETHYL-1,3-DIOXOLANE; (4R,5R)-BIS[(DICYCLOHEXYLPHOSPHINO)METHYL]-2,2-DIMETHYL-1,3-DIOXOLANE |
| (-)-4'-nitrotartranilic acid | 206761-80-0 | C10H10N2O7 | 270.2 | |
| (-)-4'-METHYLTARTRANILIC ACID | 206761-78-6 | C11H13NO5 | 239.22 | (-)-4'-METHYLTARTRANILIC ACID |
| (-)-4'-FLUOROTARTRANILIC ACID | 238401-54-2 | C10H10FNO5 | 243.19 | (-)-4'-FLUOROTARTANILIC ACID; (+)-4'-FLUOROTARTARANILIC ACID; (-)-4'-FLUOROTARTRANILIC ACID; (+)-4'-Fluorotaranilic acid; (S)-(-)-4'-Fluorotartranilicacid |
| (-)-4-[(4aR*,10bS*)-9-Ethoxy-8-methoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c]-1,6-naphthyridin-6-yl]-N,N-diisopropylbenzamide | 207993-12-2 | C29H39N3O3 | 477.65248 | Pumafentrine; UNII-063D2YI19E; Pumafentrine[INN]; AC1MHJYR; SCHEMBL26718; CHEMBL2106994 |
| (-)-3-Pyrrolidinecarboxylic acid ethyl ester | 81049-29-8 | C7H13NO2 | (-)-3-Pyrrolidinecarboxylic acid ethyl ester; Pyrrolidine-3-carboxylic acid ethyl ester | |
| (-)-3-Carboxy-2,2,5,5-tetramethylpyrrolidinyl-1-oxy | 68354-47-2 | C9H16NO3 | 186.23 | (-)-3-CARBOXY-2,2,5,5-TETRAMETHYLPYRROLIDINYL-1-OXY; (-)-3-CARBOXY-PROXYL |
| (-)-3,4,5,6,7,8-hexahydro-1-[(4-hydroxyphenyl)methyl](1H)-isoquinoline-2-carbaldehyde | 94006-07-2 | C17H21NO2 | 271.35414 | (-)-3,4,5,6,7,8-hexahydro-1-[(4-hydroxyphenyl)methyl](1H)-isoquinoline-2-carbaldehyde; (-)-3,4,5,6,7,8-Hexahydro-1-(4-hydroxybenzyl)isoquinoline-2(1H)-carbaldehyde |
| (-)-3-(TRIFLUOROACETYL)CAMPHOR 98 | 207742-84-5 | C12H15F3O2 | 248.242 | (-)-3-(Trifluoroacetyl)camphor; 3-Trifluoroacetyl-D-camphor; 207742-84-5; 3-(Trifluoroacetyl)-D-camphor; Bicyclo[2.2.1]heptan-2-one,1,7,7-trimethyl-3-(trifluoroacetyl)-,(1R)-; 51800-98-7 |
| (-)-2-METHYL-D3-ISOBORNEOL | 135441-89-3 | C11H17D3O | 171.3 | (1R,2R,4R)- |
| (-)-2-Isopropylidene-2,3-dihydroxy-1,4-bis[bis(2-methylphenyl)phosphino]butane | 57221-94-0 | C35H40 O2 P2 | 554.63800 | |
| (-)-2,3-Dibenzoyl-L-tartaric acid | 22333-70-6 | C18H14O8 | 358.30 | (-)-2,3-Dibenzoyl-L-tartaric acid; Dibenzoyltartaric acid |
| (-)-1-[1-(4-Chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)-sulfonyl]piperazine | 163837-56-7 | C24H25ClN2O2S | 440.99 | 1-[(4-CHLOROPHENYL)(PHENYL)METHYL]-4-[(4-METHYLPHENYL)SULFONYL]PIPERAZINE; (-)-1-[1-(4-CHLOROPHENYL)PHENYLMETHYL]-4-[(4-METHYLPHENYL)SULFONYL]PIPERAZINE |
| (-)-1,2-Bis[(2R,5R)-dimethylphospholano]benzene(cyclooCtadiene)rhodium(I) tetrafluoroborate | 210057-23-1 | C26H40P2Rh.BF4 | 604.26 | (-)-1,2-BIS((2R,5R)-DIMETHYLPHOSPHOLANO)BENZENE(CYCLOOCTADIENE)RHODIUM(I) BF4; (-)-1,2-BIS((2R,5R)-2,5-DIMETHYLPHOSPHOLANO)BENZENE(CYCLOOCTADIENE)RHODIUM (I) TETRAFLUOROBORATE; (-)-1,2-BIS((2R,5R)-2,5-DIMETHYLPHOSPHOLANO)BENZENE(CYCLOOCTADIENE)RHODIUM(I)T |
| (-)-1,2-BIS((2S,5S)-2,5-DIMETHYLPHOSPHOLANO)ETHANE(CYCLOOCTADIENE)RHODIUM (I) TETRAFLUOROBORATE | 213343-65-8 | C22H40BF4P2Rh- | 556.21 | (-)-1,2-BIS((2S,5S)-2,5-DIMETHYLPHOSPHOLANO)ETHANE(CYCLOOCTADIENE)RHODIUM (I) TETRAFLUOROBORATE; (S,S)-ME-BPE-RH; (-)-1,2-Bis((2S,5S)-2,5-dimethylphospholano)ethane(cyclooctadiene)rhodium(I)tetrafluoroborate,98+%(S,S)-Me-BPE-Rh; (-)-1,2-Bis((2S,5S)-2,5-di |
| (-)-1,2-BIS((2S,5S)-2,5-DIETHYLPHOSPHOLANO)ETHANE | 136779-27-6 | C18H36P2 | 314.43 | (S,S)-ET-BPE; (-)-1,2-BIS((2S,5S)-2,5-DIETHYLPHOSPHOLANO)ETHANE; (-)-1,2-Bis[(2S,5S)-2,5-diethylphospholano]ethane, Kanata purity; (-)-1,2-Bis((2S,5S)-2,5-diethylphospholano)ethane,98+%(S,S)-Et-BPE |
| (-)-1,2-BIS((2R,5R)-2,5-DIETHYLPHOSPHOLANO)BENZENE | 136705-64-1 | C22H36P2 | 362.47 | (2R,2'R,5R,5'R)-2,2'-5,5'-TETRAETHYL-1,1'-(1,2-PHENYLENE)DIPHOSPHOLANE; (2R,2'R,5R,5'R)-2,2'-5,5'-TETRAETHYL-1,1'-(O-PHENYLENE)DIPHOSPHOLANE; (-)-1,2-BIS((2R,5R)-2,5-DIETHYLPHOSPHOLANO)BENZENE; (R,R)-ETHYL-DUPHOS; (R,R)-ET-DUPHOS; (-)-1,2-Bis[(2R,5R)-2,5- |
| (-)-1,1'-BIS((2S,4S)-2,4-DIETHYLPHOSPHOTANO)FERROCENE | 290347-66-9 | C24H36FeP2 10* | 442.34 | (S,S)-ET-FERROTANE(TM); (-)-1,1'-BIS[(2S,4S)-(2,4-DIETHYLPHOSPHONATO)FERROCENE]; (-)-1,1'-BIS((2S,4S)-2,4-DIETHYLPHOSPHOTANO)FERROCENE; Bisdiethylphosphotanoferrocene; (-)-1,1'-Bis((2S,4S)-2,4-diethylphosphotano)ferrocene,min.95%(S,S)-Et-FerroTANE; (-)-1, |
| ()-1-(tert-butylamino)-3-[(3,4-dihydro-2H-1-benzothiopyran-8-yl)oxy]propan-2-ol hydrochloride | 33580-30-2 | 331.905 | ||
| (-)-(S)-5-BROMO-N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-2-HYDROXY-3-METHOXYBENZAMIDE | 128600-22-6 | C15H21BrN2O3 | 357.24 | (-)-(S)-5-BROMO-N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-2-HYDROXY-3-METHOXYBENZAMIDE; NOR-FLB 457; BENZAMIDE, 5-BROMO-N-[[(2S)-1-ETHYL-2-PYRROLIDINYL]METHYL]-2-HYDROXY-3-METHOXY; FLB 604 |
| (-)-(S)-5-BROMO-2,3-DIMETHOXY-N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-BENZAMIDE | 107188-74-9 | C16H23BrN2O3 | 371.27 | ISOREMOXIPRIDE; BENZAMIDE, 5-BROMO-2,3-DIMETHOXY-N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-, (S)-; BENZAMIDE, 5-BROMO-N-[[(2S)-1-ETHYL-2-PYRROLIDINYL]METHYL]-2,3-DIMETHOXY-; FLB 457; (-)-(S)-5-BROMO-2,3-DIMETHOXY-N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-BENZAMIDE; 5-B |
| (-)-(R)-N,N-Dimethyl-1-[(R)-2-(diphenylphosphino)ferrocenyl]ethylamine | 74311-54-9 | |||
| (-)-(R)-N-(3,4-Dihydro-2H-1-benzofuran-2-ylmethyl)-N-[5-(4-fluorophenyl)-3-pyridylmethyl]amine | 177975-08-5 | C22H21FN2O | 348.42387 | |
| (-)-(8,8-DICHLOROCAMPHORYLSULFONYL)OXAZIRIDINE | 139628-16-3 | C11H13Cl2NO4S | 326.2 | (-)-3,3-DICHLORO-2,N-EPOXY-EXO-10,2-BORNANESULTAM; (-)-(8,8-DICHLOROCAMPHORYLSULFONYL)OXAZIRIDINE; 4H-4a,7-Methanooxazirino3,2-i2,1benzisothiazole, 8,8-dichlorotetrahydro-9,9-dimethyl-, 3,3-dioxide, (4aR,7R,8aS)- |
| (-)-(6S)-4,10-DIMETHYL-7-ISOPROPYL-1,5-DIOXASPIRO[5.5] UNDEC-3-EN-2-ON | 105252-84-4 | C14H22O3 | 238.32 | (-)-(6S)-4,10-DIMETHYL-7-ISOPROPYL-1,5-DIOXASPIRO[5.5] UNDEC-3-EN-2-ON; (-)-(6S)-4,10-DIMETHYL-7-ISOPROPYL-1,5-DIOXASPIRO[5.5] UNDEC-3-EN-2-ON 98+% |
| (-)-(6R)-4,10-Dimethyl-7-isopropyl-1,5-dioxaspiro[5.5]undec-en-2-on | 105367-62-2 | C14H22O3 | 238.32 | (6R)-(-)-4,10-DIMETHYL-7-ISOPROPYL-1,5-DIOXASPIRO[5.5]UNDEC-3-EN-2-ON; (-)-(6R)-4,10-Dimethyl-7-isopropyl-1,5-dioxaspiro[5.5]undec-en-2-on; (-)-(6R)-4,10-DIMETHYL-7-ISOPROPYL-1,5-DIOXASPIRO[5.5] UNDEC-EN-2-ON 99+% |
| ((Z)-3-FLUORO-2-PHENYL-ALLYL)-HYDRAZINE | 843651-70-7 | C9H11FN2 | 166.1954432 | |
| (-)-(3R,4R)-3-(PROPYLAMINO)-6-METHOXY-1-BENZOPYRAN-4-OL MANDELATE SALT | 123671-95-4 | C21H27NO6 | 389.44 | (-)-(3R,4R)-3-(PROPYLAMINO)-6-METHOXY-1-BENZOPYRAN-4-OL MANDELATE SALT |
| (-)-(2S,3S)-2,3-Epoxy-3-cyclohexyl-1-propanol | 115362-12-4 | C9H16O2 | 156.22 | (-)-(2S,3S)-2,3-epoxy-3-cyclohexyl-1-propanol; (-)-(2S,3S)-2,3-Epoxy-3-cyclohexyl-1-propanol |
| (-)-(2R,3R)-TRANS-2-HYDROXY-3-(4-PHENYLPIPERIDINO)-5-(2-TOSYLOXYETHOXY)-TETRALIN | 153215-71-5 | C30H35NO5S | 521.67 | (-)-TEBV; TEBV; (-)-(2R,3R)-TRANS-2-HYDROXY-3-(4-PHENYLPIPERIDINO)-5-(2-TOSYLOXYETHOXY)-TETRALIN; 2-NAPHTHALENOL, 1,2,3,4-TETRAHYDRO-5-[2-[[(4-METHYL-PHENYL)SULFONYL]OXY]ETHOXY]-3-(4-PHENYL-1-PIPERIDINYL)-, (2R-TRANS)-; (-)-5-(2-TOSYLOXYETHOXY)-BENZOVESAM |
| (-)-(2R,3R)-TRANS-2-HYDROXY-3-(4-PHENYLPIPERIDINO)-5-(2-FLUOROETHOXY)-TETRALIN | 153215-70-4 | C23H28FNO2 | 369.47 | (-)-FEBV; (-)-5-(2-FLUOROETHOXY)-BENZOVESAMICOL; (-)-(2R,3R)-TRANS-2-HYDROXY-3-(4-PHENYLPIPERIDINO)-5-(2-FLUOROETHOXY)-TETRALIN; 2-NAPHTHALENOL, 5-(2-FLUOROETHOXY)-1,2,3,4-TETRAHYDRO-3-(4-PHENYL-1-PIPERIDINYL)-, (2R-TRANS)-; (-)-(2R,3R)-trans-2-hydroxy-3- |
| ()-(1S,5R)-cis-Bicyclo[3.2.0]hept-2-en-6-one | 71155-04-9 | 108.14 | ||
| (-)-(1S,4R)-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID | 102579-72-6 | C6H9NO2 | 127.14 | (-)-(1S,4R)-GAMMA-HOMOCYCLOLEU-2-ENE; (1R,4R)-4-Aminocyclopent-2-enecarboxylic acid; (1S,4R)-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID 95%, (98% E.E.) |
| (-)-(1R,3S)-3-AMINOCYCLOPENTANECARBOXYLIC ACID | 19042-34-3 | C6H11NO2 | 129.16 | (-)-(1R,3S)-BETA-HOMOCYCLOLEUCINE |
| (-)-(1R,2R,5S)-NEOMENTHYL ACETATE | 146502-80-9 | C12H22O2 | 198.3 | (-)-(1R,2R,5S)-NEOMENTHYL ACETATE; (1R)-(-)-NEOMENTHYL ACETATE; NEOMENTHYLACETATE, (1R)-(-)-; (-)-(1R,2R,5S)-NEOMENTHYL ACETATE, TERPE NE STANDARD; NEOMENTHYLACETATE, (1R)-(-)-(RG) |
| ((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-hydroxyphenyl)propanoate | 144256-11-1 | C15H20O5 | 280.32 | (4S)-(2,2-dimethyl-1,3-dioxolan-4-yl)-3-(4- hydroxybenzene) propanoic acid,methyl ester (Landiolol); ((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-hydroxyphenyl)propanoate; Benzenepropanoic acid, 4-hydroxy-, [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methy |
| ((R)-2-CHLORO-PROPYL)-BENZENE | 55449-46-2 | C9H11Cl | 154.63664 | ((R)-2-CHLORO-PROPYL)-BENZENE |
| ((Pentafluoroethyl)thio)-benzene | 65538-00-3 | C8H5F5S | 228.182316 | ((Pentafluoroethyl)thio)-benzene |
| ((E)-BUT-1-EN-3-YNYL)-BENZENE | 146276-26-8 | C10H8 | 128.17052 | ((E)-BUT-1-EN-3-YNYL)-BENZENE |
| ((5-Thiazolyl)methyl)-(4-nitrophenyl)carbonate hydrochloride | 154212-59-6 | 316.71 | ((5-thiazolyl)methyl)-(4-nitrophenyl)carbonate hydrochloride; carbonic acid 4-nitrophenyl 5-thiazolylmethyl ester hydrochloride; 5-THIAZOLYLMETHYL 4-NITROPHENYLCARBONATE, MONOHYDROCHLORIDE; 5-(Thiazolyl)methyl 4-nitrobenzoate hydrochloride | |
| ((4-METHYL-2-PYRIDYLAMINO)METHYLIDENE)MALONIC ACID DIETHYL ESTER | 19056-88-3 | C14H18N2O4 | 278.3 | ((4-METHYL-2-PYRIDYLAMINO)METHYLIDENE)MALONIC ACID DIETHYL ESTER |
| ((3S,4R)-4-(4-chlorophenyl)pyrrolidin-3-yl)methanol | 55438-52-3 | C11H14ClNO | 211.69 | ((3S,4R)-4-(4-CHLOROPHENYL)PYRROLIDIN-3-YL)METHANOL |
| ((3R,4S)-4-(3-Fluorophenyl)pyrrolidin-3-yl)methanol | 915390-10-2 | C11H14FNO | 195.23 | ((3R,4S)-4-(3-FLUOROPHENYL)PYRROLIDIN-3-YL)METHANOL |
| ((3-FLUOROPHENYL)METHYLENE)METHANE-1,1-DICARBONITRILE | 2972-71-6 | C10H5FN2 | 172.16 | AKOS USSH-4110219; ((3-FLUOROPHENYL)METHYLENE)METHANE-1,1-DICARBONITRILE; 2-(3-FLUOROBENZYLIDENE)-MALONONITRILE; RARECHEM AL BX 0054 |
| ((3-BROMO-4-METHOXYPHENYL)METHYLENE)METHANE-1,1-DICARBONITRILE | 313670-97-2 | C11H7BrN2O | 263.09 | RARECHEM AL BX 0247; CHEMBRDG-BB 5284071; ((3-BROMO-4-METHOXYPHENYL)METHYLENE)METHANE-1,1-DICARBONITRILE; (3-BROMO-4-METHOXYBENZYLIDENE)MALONONITRILE |
| ((3aR,7aR)-octahydro-1H-isoindol-3a-yl)methanol HCl | 1212106-97-2 | 0 | ((3aR,7aR)-octahydro-1H-isoindol-3a-yl)methanol HCl | |
| ((3,4-DIMETHOXYPHENYL)METHYLENE)METHANE-1,1-DICARBONITRILE | 2972-80-7 | C12H10N2O2 | 214.22 | RARECHEM AL BX 0062; ((3,4-DIMETHOXYPHENYL)METHYLENE)METHANE-1,1-DICARBONITRILE; 2-(3,4-DIMETHOXYBENZYLIDENE)-MALONONITRILE; AKOS USSH-4110228 |
| ((2R,5S)-tetrahydrofuran-2,5-diyl)bis(methylene) bis(4-methylbenzenesulfonate) | 165879-74-3 | |||
| ((2R,3S)-3-(tert-butyldiphenylsilyloxy)-2,3-dihydrofuran-2-yl)methanol | 130277-32-6 | C21H26O3Si | 354.51484;g/mol | [(2R,3S)-3-[tert-butyl(diphenyl)silyl]oxy-2,3-dihydrofuran-2-yl]methanol; ((2R,3S)-3-(tert-butyldiphenylsilyloxy)-2,3-dihydrofuran-2-yl)methanol; 130277-32-6; SCHEMBL867354; KBTVVVZXWWKUKA-VQTJNVASSA-N; CS-M0014 |
| ((2E)-2-[(2Z)-2-(3-ETHYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE)ETHYLIDENE]-2,3-DIHYDRO-1H-INDEN-1-YLIDENE)MALONONITRILE | 2510-09-0 | C23H17N3S | 367.47 | PROPANEDINITRILE, [2-[(3-ETHYL-2(3H)-BENZOTHIAZOLYLIDENE)ETHYLIDENE]-2,3-DIHYDRO-1H-INDEN-1-YLIDENE]-; ((2E)-2-[(2Z)-2-(3-ETHYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE)ETHYLIDENE]-2,3-DIHYDRO-1H-INDEN-1-YLIDENE)MALONONITRILE; D1,A-INDANMALONONITRILE, 2-[2-(3-ETHYL |
| ((2-Chloroethoxy)methylene)dibenzene | 32669-06-0 | C15H15ClO | 246.73 | 1,1'-((2-Chlorethoxy)methylene)bisbenzene; 1-Chloro-2-(diphenylmethoxy)ethane; Benzene, 1,1'-[(2-chloroethoxy)methylene]bis-; Benzhydryl beta-chloroethyl ether; TIMTEC-BB SBB007904; BENZHYDRYL 2-CHLOROETHYL ETHER |
| ((2,3,4-Trichlorophenyl)thio)acetic acid | 71965-10-1 | C8H5Cl3O2S | 271.5481 | |
| ((2 5-DIBUTOXY-1 4-PHENYLENE)BIS(METHYL& | 229494-69-3 | [OCH2(CH2)2CH3]2C6H2(CH2P)2[(C6H5)3Br]2 | 932.74 | [2,5-dibutoxy-4-(triphenylphosphaniumylmethyl)phenyl]methyl-triphenylphosphanium; dibromide; 229494-69-3; (BIS(METHYL&; ((25-DIBUTOXY-14-PHENYLENE)BIS(METHYL& |
| ((1S,2S)-2-(aminomethyl)cyclopropyl)methanol | 16177-56-3 | C5H11NO | 0 | SCHEMBL6758042;MolPort-028-919-445;(2-Aminomethylcyclopropyl)methanol;[2-(aminomethyl)cyclopropyl]methanol;AKOS022177774;AK-41856 |
| ((1R,2R)-2-AMINO-CYCLOHEXYL)-METHANOL | 5691-15-6 | C7H15NO | 129.2001 | |
| ((1E,3E)-4-CHLORO-BUTA-1,3-DIENYL)-BENZENE | 18684-87-2 | C10H9Cl | 164.63146 | ((1E,3E)-4-CHLORO-BUTA-1,3-DIENYL)-BENZENE |
| (((3E)-2-CHLORO-3-[(2Z)-2-(3-ETHYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE)ETHYLIDENE]CYCLOHEX-1-EN-1-YL)METHYLENE)MALONONITRILE | 69415-11-8 | C21H18ClN3S | 379.91 | (((3E)-2-CHLORO-3-[(2Z)-2-(3-ETHYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE)ETHYLIDENE]CYCLOHEX-1-EN-1-YL)METHYLENE)MALONONITRILE; PROPANEDINITRILE, [[2-CHLORO-3-[(3-ETHYL-2(3H)-BENZOTHIAZOLYLIDENE)ETHYLIDENE]-1-CYCLOHEXEN-1-YL]METHYLENE]- |
| ( Z )-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetic acid | 110130-88-6 | C7H7N3O4S | 229.21 | ATAIA; 4-THIAZOLEACETIC ACID, ALPHA-[(ACETYLOXY)IMINO]-2-AMINO-, (Z)-; (Z)-2-(2-AMINOTHIAZOL-4-YL)-2-ACETYLOXYIMINOACETIC ACID; ATAIA:( Z )-2-(2-AMINOTHIAZOL-4-YL)-2-ACETYLOXYIMINOACETIC ACID; ( Z )-2-(2-AMINOTHIAZOL-4-YL)-2-ACETYLOXYIMINOACETIC ACID (ATA |
| ( /-)2-(2-Chloroethyl)-1-methyl piperidine | 50846-01-0 | C8H16ClN | 0 | ( /-)2-(2-Chloroethyl)-1-methyl piperidine; 2-(2-Chloroethyl)-1-methylpiperidine |
| ( )-Mod Diop | 122977-44-0 | 0 | (+)-MOD-DIOP | |
| JE-2147 | 186538-00-1 | |||
| Sunitinib Impurity G | 1217216-61-9 | |||
| Octahydro-1H-1,4,7-triazonine Trihydrochloride | 58966-93-1 | |||
| PMPA sodium salt | 373645-42-2 | |||
| MRTX849 | 2326521-71-3 | |||
| Fulacimstat | 1488354-15-9 | |||
| Diphenhydramine citrate | 88637-37-0 | |||
| Anamorelin | 249921-19-5 |